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RESUMEN 
 
La obesidad es un problema de salud pública mundial. Contrariamente a la idea general de 
que los resultados de un estado de obesidad solo afectan al mismo individuo, ahora está claro 
que existe una asociación directa entre la obesidad materna y un aumento de los riesgos 
cardiometabólicos en la progenie. En varias enfermedades cardiovasculares, la disfunción 
endotelial suele ser el evento más temprano que se presenta, mucho antes de que se pueda 
evidenciar clínicamente la hipertensión. En las arterias placentarias y umbilicales de recién 
nacidos grandes para su edad gestacional y de madres obesas (LGA-OM, su acrónimo en 
inglés), se ha descrito una disfunción endotelial relacionada con una alteración en la respuesta 
antioxidante y niveles elevados de marcadores oxidativos circulantes. Sin embargo, no hay 
evidencia, hasta el momento, que muestre el posible efecto del ambiente pro-oxidante 
inducido sobre la maquinaria antioxidante de células endoteliales umbilicales de recién 
nacidos  LGA-OM; incluyendo el desconocimiento de  cómo la alterada fisiología perinatal 
presente a lo largo del desarrollo fetal, puede alterar el rendimiento vascular. En esta tesis, 
se probó la hipótesis de que el estrés oxidativo crónico inducido por la obesidad materna 
puede modular la fisiología vascular fetal mediante una modificación en el rendimiento de la 
maquinaria antioxidante. Al usar una sonda fluorescente sensible al H2O2, se evidenció una 
mayor capacidad antioxidante cuando se indujo un desafío oxidativo exógeno en células 
endoteliales de la arteria umbilical humana (HUAEC) aisladas de recién nacidos LGA-OM. 
Esta condición no solo estaba relacionada con una expresión basal del gen HMOX1 elevada; 
sino también, con una transcripción exacerbada del gen GPX1; asociado a un estado abierto 
de la cromatina en el promotor, de este último, sugiriendo la participación de mecanismos 
epigenéticos. Por lo tanto, propusimos que posiblemente una activación constante del gen 
GPX1 debido al estrés oxidativo ambiental podría inducir el rendimiento de respuesta 
exacerbada mediante la adquisición de una memoria transcripcional epigenética (ETM, su 
acrónimo en inglés). Para evaluar esta idea, aplicamos un protocolo de “doble impacto” a las 
células de control HUAEC y EA.hy926. Al contrario de lo que se esperaba, solo el gen 
HMOX1 mostró una respuesta similar a la ETM. En dicho gen, el primer desafío oxidativo 
indujo un estado abierto de cromatina tanto en su promotor proximal como en el enhancer 2 
(ubicado a 9 kilobases río arriba); los que se asociaron, respectivamente, a un 
13 
 
enriquecimiento de RNAPII pausada y al factor de transcripción NRF2. Todos los datos 
obtenidos en esta tesis indican que el estrés oxidativo, por sí mismo, podría actuar como un 
factor que puede modular la futura respuesta del gen HMOX1; pero, que  no es suficiente 
para modular otros genes antioxidantes como GPX1. Como perspectiva, proponemos que 
ETM podría ser parte del mecanismo involucrado en la programación fetal de la disfunción 
endotelial in vivo; Aunque, aún es necesario encontrar la señalización específica. 
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ABSTRACT 
Obesity is a worldwide public health problem. Contrary to the general idea that the outcomes 
from an obesity state only affect to the individual, it is now clear that a direct association 
between maternal obesity and an increased cardiometabolic risks in the progeny. In several 
cardiovascular diseases, endothelial dysfunction is usually the earliest event present, much 
before hypertension can be clinically evidenced. In placental and umbilical arteries from 
large for gestational age newborn from obese mothers (LGA-OM), endothelial dysfunction 
has been described, related to an alteration in the antioxidant response and to elevated levels 
of circulating oxidative markers. However, there is no evidence at the time showing the 
possible effect of the pro-oxidant environment induced in LGA-OM on the antioxidant 
machinery in umbilical endothelial cells; including how the altered perinatal physiology 
present throughout fetal development, can alter the vascular performance. In this thesis, the 
hypothesis that maternal obesity-induced chronic oxidative stress can modulate the fetal 
vascular physiology by a modification on the antioxidant machinery performance was tested. 
Using an H2O2-sensitive fluorescent probe an increased antioxidant capacity when exposed 
to exogenous oxidative challenge was evidenced in human umbilical artery endothelial cells 
(HUAEC) isolated from LGA-OM. This condition was not only related to an elevated basal 
HMOX1 gene expression but also to an over-responsive GPX1 gene transcription; associated 
to an open state of the chromatin in the promoter, suggesting the involvement of epigenetic 
mechanisms. Thus, we proposed that possibly a constant activation of the GPX1 gene due to 
the environmental oxidative stress could induce the over-responsive performance by the 
acquisition of an epigenetic transcriptional memory (ETM). To evaluate this idea we applied 
a double hit protocol to control-HUAEC and EA.hy926 cells. Contrary to what was expected 
only HMOX1 gene showed an ETM-like response. However, when induced by the first 
oxidative challenge, an open state of chromatin in both its proximal promoter and enhancer 
2 (located 9 kilo base upstream) were associated to an enrichment of paused-RNAPII and 
NRF2 transcription factor, respectively. All the data indicate that oxidative stress, by itself, 
could act as a factor that can modulate the future response of HMOX1 gene, but it is not 
sufficient to modulate other antioxidant genes and GPX1. As perspective, we propose that 
ETM could be part of the mechanism involved in the fetal programming of endothelial 
dysfunction in vivo; although, still is necessary to find the specific signaling.   
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CHAPTER 1 
 
GENERAL INTRODUCTION 
THE MOLECULAR BASES OF VASCULAR PROGRAMMING IN LARGE FOR 
GESTATIONAL AGE NEWBORN FROM WOMEN WITH PREGESTATIONAL 
OBESITY  
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GENERAL INTRODUCTION 
THE MOLECULAR BASES OF VASCULAR PROGRAMMING IN LARGE FOR 
GESTATIONAL AGE NEWBORN FROM WOMEN WITH PREGESTATIONAL 
OBESITY 
Introduction 
Developmental origin of health and diseases (DOHaD), also known as fetal programming, is 
the field of medical sciences that studies how certain conditions in susceptible periods of 
development can modulate the physiology of an individual at birth and throughout life. Many 
epidemiological reports have described that maternal nutritional status, as well as some 
obstetrical conditions, can increase cardiometabolic risk in the offspring. 
Obesity is a global epidemic1, and an important public health issue due to the elevated risk 
of developing chronic, non-communicable diseases2 such as type 2 diabetes, obesity, 
hypertension, among others. Chile is not far from this situation and the last national health 
survey showed that 31,2% of the adult populations presents obesity3. Near 31% of women in 
reproductive age begin their pregnancy with obesity3. Maternal obesity is one of the leading 
causes of infant obesity and an elevated risk of cardiometabolic disease4. 
When neonatal weight is greater than p90 for a determined gestational age, that newborn is 
classified as large for gestational age (LGA)and macrosomic, when the birth weight is ≥ 4 
kg.5–7. The elevated cardio-metabolic risk in individuals born LGA from women with 
pregestational obesity has been described through all ages: as early as the neonatal period8, 
childhood9,10, adolescence9, and adulthood11.  
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Big efforts have been done to try to understand how vascular physiology changes during the 
intrauterine period. In humans, the earliest time window to obtain fetal vascular samples are 
the placenta and umbilical cord collected at delivery. In placental chorionic arteries, isolated 
from LGA newborn, endothelial dysfunction was described 8,12. These findings indicate that 
the altered nutritional status of the mother influences the setting of vascular physiology of 
the offspring actually begins during fetal life. 
The main aim of this thesis is to find the molecular/epigenetic mechanisms that underlie the 
altered antioxidant defense associated with endothelial dysfunction in large for gestational 
age newborn (LGA) from obese mothers. Primary cell culture of human artery endothelial 
cell (HUAEC) isolated from control and LGA newborn was used as a model to find basal 
differences, and those unveiled after an acute oxidant stimulus, on the antioxidant capacity 
at the cellular and molecular level. Additionally, EA.hy926 endothelial cell line was used to 
evaluate if pro-oxidant agents can induce epigenetic transcriptional memory (ETM). 
In order to offer a better understanding of the results and discussion showed in the following 
chapter, the general topics of endothelial cell physiology, epigenetic and gene expression 
regulatory mechanism are briefly reviewed. 
Programming of vascular dysfunction  
The relationship between birthweight and cardiovascular performance during life has been 
previously indicated. Maternal obesity has been associated with cardiovascular-related 
diseases such as angina, stroke and peripheral vascular disease in the offspring in adulthood13. 
Endothelial cells (ECs) are central in vascular function,14 modulating smooth muscle tone,15 
immune cell adhesion, and activation and its altered function is an early event in 
18 
 
arteriosclerosis16, hypertension17 and diabetes18. Endothelial dysfunction is defined as “an 
imbalance between vasodilating and vasoconstricting substances produced by (or acting on) 
endothelial cells”19, and vascular programming has been broadly studied during fetal life. In 
150 days old mice progeny from dams fed a high-fat diet, showed an altered endothelium-
dependent relaxation, induced by low levels of nitric oxide (NO), Endothelium-Derived 
Hyperpolarizing Factor (EDHF) or prostacyclin PGI2, together with increased systolic 
pressure20. It has been evidenced that the setting of vascular performance starts during 
development, in utero. Schneider et al. evidenced endothelial dysfunction in chorionic 
arteries isolated from IUGR and LGA newborn and suggested that oxidative stress was at 
least one of the components of the abnormal vascular tone and NO-dependent relaxation 
observed8. 
Oxidative stress (OxS) 
Oxidative stress occurs when reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) surpass the antioxidant defense capacity in a cell or organism21. The term ROS 
describes O2-derived free radicals such as superoxide anion (O2•−), hydroxyl (HO•), peroxyl 
(RO2•) and alkoxyl (RO•); as well, O2-derived free nonradicals such as hydrogen peroxide 
(H2O2)
22. In endothelial cells, high superoxide and NO production induce the formation of 
peroxynitrite (ONOO−)27, which nitrates tyrosine residues to form nitrotyrosine in proteins28. 
In general, ROS and their derivates can attack most of the functional molecules in the cell 
including lipids29, proteins30, and DNA31. 
To deal with pathophysiological levels of ROS/RNS, cells possess complex interconnected 
antioxidant enzymatic and non-enzymatic systems. Members of the enzymatic system are 
SOD, catalases, glutathione peroxidases (GPx), thioredoxin and peroxiredoxin32. The non-
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enzymatic system includes glutathione (GSH), vitamin C, bilirubin, vitamin E, carotenoids 
and flavonoids33. In parallel, several oxidative stress-induced transcription factors (TF) like 
SP134, Oct-135, FOXO36, PPARγ37, HIF1α38, and NRF239 transactivate antioxidant enzymes 
coding genes.  
The influence of maternal obesogenic diet on redox status and antioxidant coding-protein 
gene expression in the offspring has been already demonstrated. Wistar rat pups from 
cafeteria-diet-fed dams showed a reduced oxygen radical absorbance capacity (ORAC) and 
catalase activity in blood together with an elevated plasma hydroperoxide, carbonyl protein 
levels, and SOD activity40. Reduced gene expression of hepatic Sod1, Sod2, Gpx1 was 
reported in the offspring of dams fed with high-fat diet during gestation and lactation41. In 
humans, high levels of catalase and SOD activities were found in cord blood of macrosomic 
newborn from obese mothers, together with elevated levels of oxidative stress markers in 
both peripheral bloods of mother and fetus42. 
NRF2, the oxidative stress sensor at a cellular level  
NF-E2 related- factor 2 (NRF2) has been named a master transcription factor since its ability 
to transactivate a plethora of antioxidant- and anti-xenobiotic-protein-coding genes43. NRF2 
is a leucine zipper transcription factor and, together with NRF1, NRF3, NF-E2 p45, and 
BACH belong to the Cap’n’Collar transcription factor family44.  
The transactivation of the gene targets of NRF2 occurs mainly by its stabilization45. In a 
steady-state cell, NRF2 is constantly polyubiquitinated by the KEAP1-CUL3/RBX1 
complex46; thus, the half-life of NRF2 is between 15 mintutes45 to 3 hours46. A direct attack 
to cysteine residues in KEAP1 by ROS can interrupt NRF2-KEAP1 interaction inducing 
NRF2 release47. Similarly, the phosphorylation of serine 40 of NRF2, among other post-
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translational modifications, has been observed generating the same effect48. Once NRF2 is 
released, it translocates to the nucleus49; where it heterodimerizes with small MAF protein G 
or K (sMAF-G/K) that is already bound to antioxidant response elements (ARE) 50 which 
consensus sequence is 3´-RTKAYnnnGCR- 5´51,52, located upstream of genes that respond 
to OxS53. For a complete activation, NRF2 is acetylated by CBP/p300 acetyl-transferase54,55. 
Interestingly, BACH1 also binds to ARE elements but induces repression of the gene 
expression (Figure 1)56. 
Mainly from cancer studies, the suggestion that the NRF2-ARE pathway can be altered by 
epigenetic mechanisms has emerged. In a human cell model of lung cancer, H3K27 tri-
methyltransferase EZH2 binds to NRF2 promoter inducing its repression57. Likewise, 
changes in TET-dependent DNA methylation pattern in NRF2, and the upregulation of NRF2 
and HMOX1 mRNA were associated with an increase in tumor resistance to the 
chemotherapeutic agent, 5-FU58. Those reports suggest that antioxidant coding genes 
transcribed by NRF2 could be controlled by epigenetic mechanisms in pathologies as obesity.  
Epigenetic regulation of gene expression 
Currently the term epigenetic refers to two different fields of study: 1) To explain how diverse 
phenotypes are inherited without a change in DNA sequence; and 2) To study how multiple 
cellular differentiation occurs from a single cell during development59. Almost all the 
epigenetic mechanisms that control the expression of genes occurs in the chromatin, which 
is the multimeric structure formed by nucleosomes. It has been described that nucleosomes 
are 145-147 bp of DNA wrapping histones, an octamer protein complex60. 
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Figure 1. Schematic model of the NRF2–KEAP1 signalling pathway. Under unstressed 
conditions, NRF2 is degraded in a KEAP1-dependent manner via the ubiquitin (Ub)–
proteasome pathway. The KEAP1 homodimer binds to single NRF2 molecules by 
means of two-site binding utilizing DLGex and ETGE motifs. Both motifs 
individually bind to a pocket in the DC (double glycine repeat and C-terminal) domain 
of KEAP1. Lysine (K) residues that reside between the two motifs are the targets of 
ubiquitination.  In response to oxidative and electrophilic stresses, NRF2 inducers 
inactivate KEAP1 via the modification of cysteine residues (Cys), and NRF2 is 
stabilized, and de novo synthesized NRF2 translocates into the nucleus. NRF2 
heterodimerizes with small Maf proteins (sMaf) and activates target genes through 
binding to the antioxidant response element (ARE), exerting cytoprotective effects 
against various noxious insults61. 
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DNA methylation 
Methylation refers to a transference of a methyl group from an S-adenosyl-L-methionine, 
SAM, (donor) to the position 5´of a cytosine which is located beside guanine (dinucleotide 
called CpG ), generating a 5-methylcytosine (5mC)62. CpG methylation is associated with 
gene repression, which is inherited through cell division63. Mainly by a reduction of 
transcription factors biding when regulatory elements in DNA include a methylable CpG64 
or by recruitment of gene repressor protein complex65–68. 
Three methyltransferases in mammalian cells, DNMT1, DNMT3a and DNMT3b62 have been 
described. From those, DNMT1 is the only one that reproduces a CpG methylation pattern 
in a new DNA strand during cell division69. Both DNMT3a and DNMT3b generate de novo 
methylation, thus leading to a new methylation pattern during gametogenesis, embryo 
development, and cellular differentiation70,71.  
The finding that the methyl group from cytosine can be transformed and, thus, eliminated 
changed all the paradigm of CpG methylation as a permanent modification. The elimination 
Ten-eleven translocation (TET) family enzymes are crucial enzymes for the remotion of the 
methyl group in cytosine because they can oxidize 5mC producing 5-hydroxymethylcytosine 
(5hmC)72.   
Post-translational histone modification 
The nucleosome-forming histones, named H2A, H2B, H3, and H473, have a C-terminal 
globular domain and an N-terminal flexible tail, by which they bind to each other and interact 
actively with DNA, respectively64. The post-translational modification of the histone tails 
includes arginine (R) methylation; lysines (K) methylation, acetylation, ubiquitination and 
sumoylation; and serine (S) and threonine (T) phosphorylation74,75. Although the histone 
modifications act in a complex manner a “histone code” model has been proposed, describing 
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that a specific histone modification pattern is related to a chromatin state induced by 
recruitment of non-histone proteins76. Of them, the histone acetylation occurs in lysine 
residues and is associated with gene expression77,78. Acetylated lysine residues can be 
deacetylated by histone deacetylase (HDAC) 78. The histone deacetylation is related to gene 
repression; even more, methylated DNA recruits HDAC and methyl-CpG-binding proteins 
(MeCPs)65,79,80. The methylation in K4, K36, and K79 of H3 and K20 of H4 are associated 
with gene expression; meanwhile, histone 3 K9 and K27 methylations are related to gene 
repression64. Also, the methyl group added to histone tails can be removed by the action of 
histones demethylases (HDM) 81. 
Histones variants  
Histone variants differ in a small number of amino acids in comparison with canonical 
histones82. Using the D. melanogaster model, H3.3 variant was found to be incorporated into 
chromatin in a DNA-replication-independent manner, showing a preferential enrichment in 
actively transcribed chromatin83. H2A.X variant is enriched in transcription start site of genes 
and present a negative correlation with 5mC; even more, its phosphorylation strongly marks 
DNA double-strand breaks in DNA82. It has been evidenced that dedicated machinery that 
recognizes select histone variant is able to induce a rapid exchange of histone variant in 
chromatin, as the H2A.Z variant exchange by SWR1 chromatin remodeling complex84. 
ATP-dependent chromatin remodeling complexes 
Those complexes are energy-driven multiprotein machineries, that allow the access to 
specific histones or DNA regions by altering nucleosome positions85. It has been proposed 
that ATPase-remodeling complexes act first by a partial releasing of DNA from histones 
(Looping) allowing histone movement (Sliding)86. Other authors have indicated that 
complete eviction of histones can also occur87. At the moment 4 families of ATPase-
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remodeling complex have been identified: SWI/SNF88, ISWI89, NURD/Mi-2/CHD90, and 
INO8091. 
Non-coding RNAs (ncRNAs) 
In human cells, the most studied short ncRNA are miRNA; which, after several processes 
from its genesis, end up as RNAs of 21 nucleotides of length that are loaded in RNA-induced 
silencing complex (RISC) and used as a guide to repress mRNA translation92. In the other 
hand long-non-codings RNAs (lncRNAs) basically, seem to have 3 main functions: 1) To 
shape nuclear organization93–95, 2) to capture miRNAs96 and 3) to modify gene expression. 
For the last, an example is the lncRNA RMST that regulates the correct localization SOX2 
transcription factor binding in neurogenesis97. 
Epigenetic mechanisms have been defined as crucial during development. In that period 
critical processes such as dosage compensation98, genes imprinting99, and protection against 
transposable elements ocurrs100. However, epigenetic mechanisms also participate in the 
inheritable fine-tuning of gene expression, such as epigenetic transcriptional memory. 
Epigenetic Transcriptional Memory (ETM) 
It has been described that some inducible genes are expressed faster and stronger when they 
are previously transcribed, several cell cycles before. The fact that the first gene 
transactivation is “remembered” by the chromatin has been called epigenetic transcriptional 
memory (ETM).101,102,103,104,105. The events and mechanisms that control ETM have been 
studied mainly in eukaryotic cells, in both yeast and human cells. This memory can be 
maintained for four or five cell divisions, without any re-stimulation in the 
meantime103,105,106. The features that characterize ETM can be summarized in 1) a second 
gene induction is faster and stronger compared to non-treated cells101; 2) the “memory” is 
maintained for four to five cell divisions105; 3) the locus of genes that acquire ETM are 
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recruited to nuclear boundary during gene transcription and they stay there for 4 to 12 hours 
after gene expression101; 4) an open state of the chromatin at the gene proximal promoter103; 
5) a long-range interaction between gene promoter and cis-regulatory modules (CRMs) 
sustained by cohesines107, forming a chromatin loop; 6) incorporation of histone variants 
H2A.Z to proximal-promoter chromatin regions101,104; 7) enrichment of H3K4me2 histone 
modification and poised-RNAPII during the “resting period” after first activation102,106 
(Figure 2).      
Mechanisms that regulate gene transcription 
For better understanding, some of the mechanisms of gene transcription regulation are 
exposed bellow, with special focus in paused-RNAPII. 
Transcription initiation 
Classically, gene transcription cycle has been divided into three phases; initiation, elongation 
and termination108,109. Initiation of transcription is a highly regulated process, which includes 
sequential events. First, the binding of specific activators, as transcription factors (TF), to 
specific sequences induces the recruitment of chromatin remodeling complexes in order to 
make the core promoter accessible to transcriptional machinery110,111. Then, the pre-initiation 
complex (PIC) is formed by the assembly of general transcription factors (TFII—A, -B, -D, 
-E, -F and –H) and RNAPII112. TFII-H generates the TSS DNA melting and one strand is 
loaded into RNAPII cleft, forming the open promoter complex113. TFII-B helps RNAPII find 
the TSS starting the productive elongation phase, called promoter clearance114. Initiation 
factors stay at the core promoter, forming the promoter-bound scaffolds, which facilitate the 
re-initiation of another RNAPII108. 
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Figure 2. Proposed model of oxidative stress-ETM acquisition in the HMOX1 gene. A) 
In an unstimulated state, Enhancer 2 has a closed-state of the chromatin (represented by ARE 
elements found in the nucleosome wrapping DNA), and BACH1 co-binding with sMAF 
proteins on non-canonical ARE sites; CpG could be methylated favoring closed chromatin 
in that region. Although the gene has a basal activity, the proximal promoter is represented 
as closed, with completely unmethylated CpG Islands. B) In a stimulated state, with gene 
expression, at Enhancer 2 the chromatin structure becomes more relaxed; BACH1 is released 
allowing NRF2 binding to sMAF protein on ARE; CBP/P300 acetyltransferase (not showed) 
acetylate histones nearby and NRF2 for full activation. Relaxed chromatin at the proximal 
promoter allows the binding of general transcription factors (GTF) and RNAPII. During the 
initiation step, serine 5 of RNAPII is phosphorylated by TFIIH kinase (not showed); the 
productive elongation step is induced by recruitment of P-ELFb (not showed), which 
phosphorylates serine 2. C) In the OxS-ETM state, Enhancer 2 maintains an open state of 
chromatin where NRF2 is enriched with sMAF co-activator protein. CpG demethylation in 
non-canonical ARE sites could facilitate NRF2 enrichment. At proximal promoter paused-
RNAPII is enriched, maintained at pausing region (+20-60 pb) by NELF and 
unphosphorylated DSIF; H3K4dimethylation (ETM hallmark in pro-inflammatory ETM 
model) could be present; CpG island pattern remains without changes. 
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Carboxy-terminal domain (CTD) RNAPII phosphorylation 
RNAPII holoenzyme is formed by a core complex of 12 subunits and a sub-complex of two 
subunits115. In human, Carboxy-Terminal Domain (CTD) of subunit 1 (Rpb1) is formed by 
a 52 tandem repetitions of a heptapeptide sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 
(YSPTSPS)116. Different phosphorylation of serine residues into CTD has been associated 
with the different phases of the transcription cycle, so-called CTD code117. Thus, 
phosphorylation of serine 5 (pS5) by cyclin-dependent kinase 7 (CDK7) happened at the 
initiation phase, and its level decreases as RNAPII moves into the gene body118–120. Serine 2 
phosphorylation by ctk1121 occurs during productive elongation phase, and it is de-
phosphorylated at the end of transcription associated with RNAPII re-cycling118,122,123. Serine 
7 phosphorylation occurs at the beginning of the transcription and is maintained until the 
end124.  
RNAPII pausing 
It has been indicated that high accumulation of RNAPII at the proximal promoter region (i.e. 
30-60 nucleotides downstream of TSS), occurs in both developmental and inducible 
genes125,126. After initiation pS5-RNAPII reach stalling site, pausing is induced by binding 
of negative elongation factor (NELF) and DRB-Sensitivity-Inducing factor (DSIF) to 
RNAPII127,128. After the stimulus, positive transcription elongation factor-b (P-TEFb) 
complex, that includes cyclin T1 and Cyclin-dependent kinase 9 (CDK9), phosphorylates 
Ser2 at CTD of RNAPII, NELF (inducing its release) and DSIF, transforming it into a 
positive elongation factor125,126,129, starting productive elongation phase of RNAPII. 
Enhancers in gene transcription regulation 
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It is known that core promoter of genes is sufficient to recruit the RNAPII machinery; 
however, the robustness of gene transcription can be increased by genomic regions located 
far away from the transcription start site (TSS). These elements are termed enhancers or cis-
regulatory modules (CRMs)130. A big amount of TF binding motifs are located there, 
allowing that the recruitment of activating or repressive TF and co-regulators modulate the 
activity of the enhancers130. Enhancers have been classified as inactive, poised, primed and 
active131. Inactive enhancers have compacted chromatin, with the absence of TF131 and, 
mainly, H3K4me1 and H3K4me2 modifications132. Additionally, H3K27me3, a repression-
associated mark, indicates a poised enhancer133. Active enhancers are featured by H3K27ac 
modification133 and the presence of an active RNAPII134. Just in the middle, primed 
enhancers contain H3K4me1 and H3K4me2 modifications but lack histone acetylations133. 
They are posed closely bound to transcription factors, maintaining a nucleosome-free 
region135 which is hypersensitive to DNase I136. 
Since the enhancer can be located at several hundred kilobases from gene promoter, a long 
range of interactions are maintained by mediator complexes137 and cohesines138. It has been 
showed that for gene transcription, the recruitment of RNAPII not only occurs at the TSS but 
also at enhancers themselves inducing the active expression of Enhancer RNAs (eRNAs)139. 
The experimental evidence suggests that eRNAs play a pivotal role in RNAPII promoter 
escape140. 
Hypothesis 
Considering the background set in the introduction, the hypothesis of this thesis is that the 
previous exposure to oxidative stress induces an epigenetic transcriptional memory in the 
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HMOX1 gene in HUAEC from large-for-gestational-age (LGA) offspring of women with pre-
gestational obesity, which can be mimicked in vitro in an endothelial cell line. 
 
General and Specific Aims 
General aim. To determine the presence of an epigenetic transcriptional memory (ETM) in 
the HMOX1 gene associated with a previous exposure to oxidative stress in LGA-HUAEC, 
and in a human endothelial cell line. 
 
Specific aim 1. To characterize the potentiated HMOX1 mRNA expression by pro-oxidant 
stimuli in LGA-HUAEC. 
Specific aim 1.1. To determine if the pro-oxidant priming induces changes in the levels 
and timing of the HMOX1 mRNA in LGA-HUAEC. 
Specific aim 1.2. To determine if the changes in the HMOX1 mRNA levels are due to the 
stability of HMOX1 mRNA in LGA-HUAEC. 
Specific aim 1.3. To determine if the treatment with a pro-oxidant agent induces changes 
in the methylation pattern at the HMOX1 proximal promoter from LGA-HUAEC. 
 
Specific aim 2. To determine the acquisition of ETM in the HMOX1 gene by pro-oxidant 
stimuli, in the endothelial cell line, EA.hy926. 
Specific aim 2.1. To standardize a model of ETM induced by a pro-oxidant stimulus in 
the HMOX1 gene in EA.hy926. 
Specific aim 2.2. To determine the presence of a poised-RNAPII at the HMOX1 gene 
proximal promoter in an ETM cell model in EA.hy926. 
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Specific aim 2.3. To evaluate the state of the chromatin at the proximal promoter of the 
HMOX1 gene proximal promoter in an ETM cell model in EA.hy926. 
Specific aim 2.4. To characterize the kinetics of the post-transcriptional modifications of 
histones during the basal, gene activation and post-activation cycle in an ETM cell model 
in EA.hy926. 
In the second chapter of this thesis, the mechanisms that define how endothelial antioxidant 
machinery from LGA newborn works under exogenous oxidative challenge are shown. In 
summary, the results show that LGA-HUAEC has a pro-oxidant environment, characterized 
by a reduced GSH:GSSG ratio and a high H2O2 tone. The latter was associated with a 
diminished level of superoxide anion and an increased SODs activity. In response to a new 
H2O2 challenge, LGA-HUAEC showed a robust global antioxidant machinery; tolerating 
higher concentrations of exogenous H2O2 and showing least efficient oxidation kinetics and 
a faster reduction rate of an H2O2-induced fluorescent probe. Although candidate antioxidant 
proteins levels in cell culture were not different compared to control cells, the in situ protein 
levels of NOX4 and SOD1 were increased. The basal mRNA level of NRF2 and HMOX1 
were reduced and elevated, respectively, in the primary cell culture model. Interestingly, 
when LGA-HUAEC cells were stimulated with H2O2 for 3 hours, GPX1 mRNA was 
overexpressed. A concurrence of an open chromatin state at GPX1 core promoter pointed to 
plausible epigenetic mechanisms. 
Considering the original hypothesis, an ETM mechanism could answer the question left by 
chapter two. ETM implies epigenetic modifications at the promoter of inducible genes, left 
in the promoter by a first stimulus, called gene priming. This priming favors an over-
expression of the gene when cells are stimulated for a second time141. The in vivo oxidative 
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stress in LGA newborn of obese mothers could act as a first priming factor in the GPX1 gene 
in HUAEC, being unmasked by a second in vitro challenge.  
In the third chapter of this thesis, the question if oxidative stress itself is necessary and 
sufficient to lead to epigenetic modifications in antioxidant coding-protein genes in an ETM 
manner. Using a pro-oxidant double hit protocol in primary control-HUAEC, EA.hy926 or 
HeLa cells, among several antioxidant-coding genes, HMOX1 gene acquired an ETM state. 
The ETM was characterized by an open chromatin state at the core promoter and enhancer 2 
(located at -9 kb from TSS) of HMOX1, together with a paused RNAPII and NRF2 
enrichment at the core promoter and enhancer 2, respectively. 
The fourth chapter comprises is a general discussion of redox status alterations on endothelial 
cell physiology; as well as the possible molecular/epigenetic mechanisms that could be 
involved in the programming of vascular function. 
This thesis shows the first evidence that maternal obesity is associated with changes in the 
antioxidant capacity of endothelial cells of LGA-offspring and proposes epigenetic 
transcriptional memory in the HMOX1 gene as a specific mechanism.  
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CHAPTER 2 
HUMAN UMBILICAL ARTERY ENDOTHELIAL CELLS FROM LARGE-FOR-
GESTATIONAL-AGE NEWBORN HAVE INCREASED ANTIOXIDANT 
EFFICIENCY AND GENE EXPRESSION. 
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ASTRACT 
Obesity is a public health problem worldwide, and especially in women in reproductive age 
where more than one in three are considered to have obesity. Maternal obesity is associated 
to an increased maternal, placental and newborn oxidative stress, which has been proposed 
as a central factor in vascular dysfunction in large-for-gestational-age (LGA) newborn. 
However, cellular and molecular mechanisms behind this effect have not been elucidated. 
Untreated human umbilical artery endothelial cells (HUAEC) from LGA (LGA-HUAEC) 
presented higher O2
¯
 levels, SOD activity and HMOX1 mRNA levels, paralleled by reduced 
GSH:GSSG ratio and NRF2 mRNA levels. In response to an oxidative challenge (H2O2), 
only HUAEC from LGA exhibited an enhanced GPX1 expression, as well as a more efficient 
antioxidant machinery measured by the biosensor probe, HyPer. An open state of chromatin 
in the TSS region of GPX1 in LGA-HUAEC was evidenced by DNase-HS assay. Altogether 
our data indicate that LGA-HUAEC have an altered cellular and molecular antioxidant 
system. We propose that a chronic pro-oxidant intrauterine milieu, as evidenced in 
pregestational obesity, could induce a more efficient antioxidant system in fetal vascular 
cells, which could be maintained by epigenetic mechanism during postnatal life. 
 
Keywords:  Oxidative stress; LGA; maternal obesity; endothelial cells; epigenetics 
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INTRODUCTION 
Pre-gestational maternal obesity and excessive weight gain during pregnancy are associated 
with high blood pressure, altered lipid profile, insulin resistance, and obesity in the offspring 
(Adamo et al., 2012; Oken & Gillman, 2003). The cellular and molecular mechanisms 
underlying the alterations caused by these maternal conditions are not completely 
understood. Oxidative stress is one of the causes of obesity-related diseases (Marseglia et al., 
2015), and elevated systemic markers of oxidative stress are reported in women with 
pregestational obesity and in the umbilical cord blood from large for gestational age (LGA) 
newborn from mothers with obesity (LGA-MO) (Malti et al., 2014)  
Oxidative stress response involves the activation of the nuclear factor erythroid 2-related 
factor 2 (NFE2L2), whose gene product, NRF2, is a master transcription factor 
transactivating a plethora of antioxidant- and antixenobiotic-protein coding genes (Ma, 
2013). NRF2 transactivates the antioxidant enzymes Glutathione Peroxidase 1 (GPX1), 
Heme Oxygenase 1 (HMOX1), and hydrogen peroxide (H2O2)-generating enzymes such as 
NADPH oxidase 4 (NOX4) and superoxide dismutases (SODs) (Ma, 2013). The genes 
coding for these pro- and anti-oxidant proteins are expressed in the human placenta and 
umbilical cord vascular cells (Barber et al., 2001; Schneider et al., 2015). However, the 
possible alteration in the expression of these genes, in umbilical artery endothelium of LGA 
newborn, has not been described so far. 
Epigenetic mechanisms explain how diverse phenotypes are mitotically inherited without a 
change in DNA sequence and how cell differentiation occurs from a single cell during 
development (Bird, 2007). DNA methylation by methyltransferases in mammalian cells 
(Reik, 2007) associates with gene repression and is inherited through cell division (Klose & 
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Bird, 2006). Compaction and relaxation of chromatin structure requires the presence and 
activity of ATP-dependent chromatin remodeling complexes allowing access to specific 
histones or DNA regions by altering the nucleosome positions (Kim et al., 2009). If 
chromatin structure is involved in the permanent effects that intrauterine oxidative stress-
related adaptations in oxidative stress genes in LGA-derived endothelium has not been 
answered hitherto. 
To answer these questions, we evaluated whether umbilical artery endothelial cells from 
LGA offspring from women with pregestational obesity show changes in their homeostatic 
redox capacity including the study of some of the most relevant genes and proteins expression 
as well as in vitro function.  
MATERIALS AND METHODS 
Samples  
This research was conducted in accordance with the Declaration of Helsinki and Ethics 
Committee approval from the Faculty of Medicine at the Pontificia Universidad Católica de 
Chile. Patient informed consent was obtained at the moment of the maternity ward admission. 
Placentae were collected immediately after delivery from full-term offspring from 
normotensive, non-smoking, non-alcohol or drug consuming mothers, without any known 
medical or obstetrical complication. Maternal nutritional status, normal weight or obesity, 
was estimated calculating maternal BMI, corrected by gestational age (Rosso, 1985). Using 
a national standard curve (Milad et al., 2010) newborn were classified in accordance to 
adequacy of weight for gestational age at birth. Neonates between percentile 10th and 90th 
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were considered adequate for gestational age and over percentile 90th as LGA. Table 1 shows 
the maternal and neonatal general and anthropometric characteristics. 
Cell isolation and culture 
Human umbilical artery endothelial cells (HUAEC) were isolated as previously described 
(Krause et al., 2013). Briefly, endothelial cells were isolated from umbilical arteries by 
collagenase digestion (0.2 mg/mL) and cultured (37°C, 5% CO2) up to passage 3 in medium-
131 containing microvascular growth supplement (MVGS), 3.2 mmol/L L-glutamine and 
100 U/ mL penicillin–streptomycin. All the experiments were made at passage 3 of the 
primary cell cultures. Prior to protein or mRNA extraction, confluent cells were starved by 
reducing the MVGS supplement to 2% and then exposed overnight to 7% O2 (oxygen partial 
pressure ~33.9 mmHg, normoxia for this cell type) using a gas mixture (5% CO2-balanced 
N2) in a hypoxia chamber connected to a PROOX 110 device (BioSpherix, NY, USA). On 
the next day the cells were exposed (or not) to H2O2 (100 μM) for 3 hours. 
HUAEC infection with HyPer probe 
Primary cultures of HUAEC, grown on 25 mm coverslips (5,000 cells/coverslip), were 
infected with 1:500 adenoviral dilution of HyPer. Two days after, cells were ready for HyPer 
imaging as previously published (Román et al., 2017). HyPer probe was constructed as 
follows. Briefly, cDNAs of cyto-HyPer (Evrogen, Moscow, Russia) were sub-cloned into the 
commercial adenoviral vector pAdEasy-RFP with conventional molecular biology 
techniques, and homologous recombination was done by BJ5183 cells transformation. 
Recombinant adenoviral plasmids were digested with PacI and transfected in HEK-AD 293 
(AdHek) cells with lipofectamine according to the manufacturer´s guidelines. Following 
observation of the cytopathic effects (CPE), usually after 14–21 days, cells were harvested 
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and subjected to three freeze–thaw cycles, followed by centrifugation to remove cellular 
debris, and the resulting supernatant (2 ml) used to infect a 10 cm dish of 90% confluent 
AdHek cells. After the observation of CPEs, normally after 2–3 days, viral particles were 
purified and expanded by infecting 10 plates of AdHek cells (Hernández et al., 2018). 
Microscopy and imaging of HyPer biosensor 
The experimental day, the HUAEC medium was replaced by Krebs-Ringer-HEPES-glucose-
glutamine (KRH) buffer (in mM: 140 NaCl, 4.7 KCl, 20 Hepes, 1.25 MgSO4, 1.25 CaCl2, 
pH 7.4) supplemented with 5 mM glucose and each coverslip was mounted in an open 
recording chamber. Images of HUAEC were registered using a Nikon Ti inverted microscope 
equipped with 40X oil objective [numerical aperture, N.A. 1.3]. A Xenon lamp was coupled 
to the monochromator device (Cairn Research Ltd, Faversham, UK). Digital images were 
acquired by means of a cooled CCD camera (Hamamatsu ORCA 03, Japan). All devices 
were synchronized and operated by using a freeware micromanager software (Edelstein et 
al., 2014). 
HyPer biosensor is composed by a circular permuted yellow fluorescent domain, suitable for 
dual excitation at 420 and 490 nm. Emitted light from these two excitation channels was 
collected with a long-pass filter over 520 nm. The biosensor signals from both excitation 
wavelengths were acquired each 20 seconds and converted in a ratio (490/420) making H2O2 
measurements reliable and independent of the biosensor expression in the cells. 
The biosensor responses were measured in HyPer-expressing C-HUAEC and LGA-HUAEC 
taking in consideration a baseline of at least 10 minutes to ensure a stable recording. Then, 
H2O2 pulses were applied (1, 5, 10, 25, 50, 100, 200 μM) to build a doses-response curve. 
All HyPer recordings ended with 1000 μM H2O2 pulse to obtain the maximal signal of the 
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biosensor. With this experimental approach, measurements at equilibrium (baseline and peak 
values) along with kinetic analysis (rising and recovery signals) of biosensor were possible. 
Dihydroethidium (DHE) assay 
In a black wall 96-well plate, previously coated with 1% of gelatin, 3x104 C-HUAEC or 
LGA-HUAEC were seeded per well and incubated for 24 hrs. Prior to the DHE load, 
confluent cells were starved reducing to 2% the MVGS supplement and exposed overnight 
to 7% O2. Cells were loaded with DHE (10 μM) and incubated for 30 minutes at 37°C in 
darkness. Cells were washed 2 times with 1x PBS (in mmol/L: 136 NaCl, 2.7 KCl, 7.8 
Na2HPO4, 1.5 KH2PO4, pH 7.4), loaded with DAPI (300 nM) and incubated during 5 
minutes at room temperature in darkness. Cells were washed 2 times with 1x PBS and 
maintained in KRH buffer (in mM: 140 NaCl, 4.7 KCl, 20 Hepes, 1.25 MgSO4, 1.25 CaCl2, 
pH 7.4) supplemented with 5 mM glucose. The fluorescence was measured immediately on 
a Synergy II microplate fluorescence reader (BioTek Instruments, VT), equipped with Gen5 
software at excitation/emission wavelength 489/<580nm and 358/461 nm, for DHE and 
DAPI respectively. DHE fluorescence was normalized by DAPI fluorescence and presented 
as DHE/DAPI ratio.  
GSH:GSSG assay 
Endothelial cells were grown in 60 mm culture dishes until they reached 70–80% confluence. 
Later, they were washed twice with PBS and scrapped in presence of hypotonic buffer (in 
M: NaCl 0.15, Na2HPO4 0.01, NaH2PO4 0.01, pH 7.4). The cell suspension was transferred 
to a1.5 mL microtube and centrifuged at 1000g for 5 min at 4°C. After the supernatant was 
discarded, the pellet was resuspended in 1 mL of cold PBS. To ensure a complete cell lysis, 
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the cell homogenates were sonicated. The cell lysate (100 µL treated with 2 µL 2-
vinylpyridine) were incubated at 37°C with 700 μL of potassium phosphate buffer with 
EDTA (KPE) (0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt, pH 7.5), 
60 µL of 280 µM NADPH and 60 µL 10 mM 5,5'-dithio-bis (2-nitrobenzoic acid) (DTNB) 
for 10 min at 30°C to oxidize all the GSH to GSSG. GSSG was then reduced by adding 60 
µL GSH reductase. The rate of TNB formation was followed at 412 nm and was proportional 
to the sum of GSH and GSSG present. The rate was compared with a standard curve of GSH 
in buffer. 
Determination of superoxide dismutase activity (SOD) 
This analysis was performed as described by Fridovich (Fridovich, 1995). In an aliquot of 
cell lysate (as previously described), the reduction of cytochrome by the superoxide radical 
in the xanthine/xanthine oxidase system, was measured by spectrophotometry. Solution A 
was composed of 0.5 mM xanthine and 20 µM cytochrome c dissolved in PBS pH 7.8; 
Solution B contained xanthine oxidase and EDTA 0.1 mM (1:40). Enzymatic activity was 
detected at 550 nm after mixing 2.9 mL solution A, 50 µL solution B and 100 µL of sample, 
and expressed as units of enzyme/mg protein using the total protein determined with the 
Lowry method (Lowry et al., 1951), using bovine albumin (BSA) as standard.  
Western blotting  
Proteins from C-HUAEC or LGA-HUAEC (40 µg) were separated in polyacrylamide gel 
(12%) electrophoresis, including a lane with 7 μl of a prestained protein ladder (cat # 26619, 
ThermoFisher, USA), and transferred to 0.45 mm PVDF membranes (BioRad). Membranes 
were blocked with 5% BSA in Tris buffered saline (TBS) with 0.1% Tween (TBST) for 1 
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hour. The membranes were probed with anti-NRF2 antibody (Thermo Fisher Scientific Cat# 
PA5-27882, RRID:AB_2545358), rabbit monoclonal anti-NOX4 antibody (Abcam Cat# 
ab109225, RRID:AB_10861375), mouse monoclonal anti-β-Actin antibody (Sigma-Aldrich 
Cat# A5316, RRID:AB_476743), mouse monoclonal anti-HMOX1 antibody (BD 
Biosciences Cat# 610712, RRID:AB_398035), rabbit monoclonal GPX1 antibody (Abcam 
Cat# ab108427, RRID:AB_10890636) or mouse monoclonal SOD1 antibody (Abcam Cat# 
ab20926, RRID:AB_445919) for 1 hour at room temperature. Membranes were washed in 
TBST, and incubated (1 h, 22 °C) in TBST containing horseradish peroxidase-conjugated 
goat anti-rabbit or anti-mouse secondary antibodies. Proteins were detected by enhanced 
chemiluminescence and quantified by densitometry using ImageJ (https://imagej.net, 
RRID:SCR_003070) as described elsewhere. 
Immunohistochemistry  
Immunohistochemistry analysis of protein expression in umbilical arteries was done as 
previously reported (Schneider et al., 2015). Briefly, umbilical cords were washed with cold 
PBS, dissected in segments of 5 mm, treated overnight with paraformaldehyde (4% in PBS) 
and included in paraffin. Deparaffinized and rehydrated histological sections of 4 mm were 
subjected to heat-induced antigen retrieval using 100 mmol/L citrate buffer (pH 6.0) in a 
steam cooker for 15 min at 95°C. Samples were treated with 3% H2O2 in PBS for 30 min to 
quench endogenous peroxidase activity. After rinsing in PBS for 5 min, all slides were 
incubated for 1 h with protein block solution (Cas- Block, Zymed Laboratories, South San 
Francisco, CA, USA). Sections were incubated overnight at 4°C with primary anti-SOD1 
(1:1000) (Abcam Cat# ab20926, RRID:AB_445919), NOX4 (1:500) (Abcam Cat# 
ab109225, RRID:AB_10861375) and GPX1 (1:500) (Abcam Cat# ab108427, 
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RRID:AB_10890636) antibodies. Immunostaining was performed using horseradish 
peroxidase (HRP)- conjugated secondary antibodies and binding was determined with 
NovaRED kit (Vector, Burlingame, CA, USA), treated for 4 min. Slides were counterstained 
with Harris hematoxylin and permanently mounted. Specificity of the staining was 
determined by incubation of sections in the absence of the primary antibody. Sections were 
examined under an IX81-Olympus microscope, and images were captured using a digital 
camera (Olympus DP-71) and software (Olympus DP-BSW). At least two slides of every 
sample were analyzed for each antibody probed in three samples from each group. 
The analyzes of the images were made using ImageJ software (https://imagej.net, 
RRID:SCR_003070).  Following the protocol previously described (Fuhrich, Lessey, & 
Savaris, 2013), the images were corrected subtracting the background, region of interest 
(ROI) containing 6 to 7 endothelial cells were selected using the drawing tool, H DAB 
deconvolution plugin was used to separate immunostaining color (i.e. brown) from 
hematoxilin color (i.e. blue), the intensity of immunostaining were measured into the 
previously generated ROIs,  and the  reciprocal intensity were calculated before statistical 
analyzes (D. Nguyen & Nguyen, 2013).  
Isolation of total RNA and reverse transcription  
Total RNA was isolated using Trizol (Invitrogen, USA) as described (Krause et al., 2016). 
RNA quality and integrity were ensured by gel visualization and spectrophotometric analysis 
(OD260/280) and quantified at 260 nm. Aliquots of 1 μg of total RNA were reversed 
transcribed using IMPROM II RT kit (Promega, USA).  
Quantitative PCR  
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Polymerase chain reactions were performed as described (Krause et al., 2013), using 
oligonucleotide primers for human genes of interest (GOI) NRF2, FOXO3A, HMOX1, GPX1, 
TXNDR, PRDX3, PRDX6, SOD1, SOD2, p66sch and NOX4. Three different mRNAs, 
RPLP0, RPLP2 and ATP5F1, were selected as reference genes for relative quantity (RQ) 
calculation, since they showed the lowest standard deviation of raw Cts in all the 
experimental groups (data not shown), as it was previously described (Mane, Heuer, Hillyer, 
Navarro, & Rabin, 2008) (Table 2). The PCR efficiency for each primer was calculated using 
a curve of cDNA made by five-fold serial dilutions (from 1x to 1/625x). All the 
amplifications were done using a 1/10 dilution of cDNA. Quantification was carried out using 
the algorithm proposed by Pfaffl (Pfaffl, 2001). The final RQ for each gene of interest (GOI) 
mRNA was calculated considering the geometrical mean of the three different reference 
genes.  
DNase Hypersensitivity assay 
DNase hypersensitivity assay was performed as described by Stewart et al. (1991). Control- 
and LGA-HUAEC were cultured in 6 well plates until confluence. After washing with PBS, 
partial DNA digestion was performed by adding 1 mL digestion buffer (in mM Tris-HCl 15 
mM pH 7.5, KC1 60 mM, NaCl 15 mM, MgCl2 5 mM, EGTA 0.5 mM, sucrose 300 mM, β-
mercaptoethanol 0.5 mM and NP40 0.5%) containing 0 U (Control) or 6.25 U of RQ1 DNase 
(Promega, USA). After incubation for 5 min at room temperature (22-25°C), the digestion 
buffer was aspirated and cells were lysed with 0.5 mL of 50 mM Tris-HCl pH 8.0, 20 mM 
EDTA, 1% SDS, Proteinase K (200 µg/mL) (ThermoFischer, USA) and RNase A (20 
µg/mL) (Affymetrix, USA); and incubated for 1 h at 37°C. DNA was extracted by Phenol-
chloroform method (Green & Sambrook, 2017). Twenty-five ng of DNA per reaction were 
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used to amplify the NRF2 transcription start site (TSS), HMOX1 TSS and GPX1 TSS (GOI) 
and PAX7 TSS as reference gene (Primer details in Table 3). The quantification was carried 
out using the algorithm proposed by Pfaffl (Pfaffl, 2001).  
Statistical analysis. 
The HyPer experiments were done in 21 and 57 single different C-HUAEC and LGA-
HUAEC respectively, derived from 3 different subjects per group. Protein and mRNA assays 
were carried out in replicates using at least 4 independents primary HUAEC cultures obtained 
from different umbilical cords. For DNase accessibility assays cell cultures from 3 different 
subjects per group were performed. For the superoxide quantification (DHE), SODs activity, 
GSH and GSSG (GSH:GSSG ratio) the HUAEC from 5 subjects of each group were used. 
Values are mean ± S.E.M. or median ± interquartile range as indicated in each figure. 
Comparisons between two treatments or conditions were performed by Mann–Whitney U or 
t-test, accordingly. All the analyses were carried out with the statistical software Graphpad 
Prism v6.01 (https://www.graphpad.com, RRID:SCR_015807). A value of p<0.05 was 
considered the cut-off for statistical significance. 
RESULTS  
LGA-HUAEC have an altered redox status and an increased exogenous H2O2 buffering 
capacity 
To evaluate if LGA-HUAEC present a modified redox status such as altered antioxidant 
machinery, we used HyPer, an oxidative stress biosensor, combined with H2O2 pulses. C- or 
LGA-HUAEC were infected with adenoviral particles containing HyPer and left proliferate 
for 48 h before H2O2 treatment. Figure 1, shows representative curves obtained in C-HUAEC 
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(Figure 1A) and LGA-HUAEC (Figure 1B), respectively. Before any treatment, baseline 
ratio values were recorded until evident stability was reached. Steady-state HyPer values 
from LGA-HUAEC were consistently higher than those observed in C-HUAEC (Figure 1C), 
suggesting a higher oxidant tone in LGA-HUAEC, possibly  due to  higher levels of 
endogenous H2O2 or a diminished disulfide reducing activity. 
To assess the antioxidant machinery in LGA-HUAEC the EC50 of Hyper fluorescence was 
estimated by recording the biosensor responses to increasing exogenous H2O2 
concentrations. These responses were later referred to a percentage of the value obtained to 
the maximal stressor tested (1 mM H2O2). The maximal value obtained for the cells from 
both groups was comparable, indicating that dynamic ranges of the biosensor were 
comparable between groups. The EC50 values were 44.9 μM and 104.9 μM for C-HUAEC 
and LGA-HUAEC, respectively (Figure 1D). The difference in the EC50 between groups 
indicates that LGA-HUAEC have an increased exogenous H2O2 buffering capacity compared 
to C-HUAEC. It is noteworthy to point that independent of the cell group tested, the biosensor 
responses were always transient upon removal of the oxidant pulse, indicating that an 
intrinsic property of the cytosolic environment acts on the biosensor redox status.  
The kinetic of the biosensor was further analyzed to assess if the antioxidant performance of 
LGA-HUAEC differed from C-HUAEC. With this purpose in mind, the HyPer signal values 
obtained in the first 300 seconds after H2O2 treatment (100 µM) were used to compare the 
kinetics of increase in both groups (Figure 1E). The C-HUAEC curve reached an equilibrium 
between 200-300 seconds after the H2O2 pulse. On the other side, the HyPer signal from 
LGA-HUAEC showed a significant slower biosensor response (Figure 1E and Table 4). 
Several parameters related to HyPer fluorescence kinetic were calculated for each group. The 
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slope, taken from the linear phase of the curve (80 to 180 s), were 0.83 ± 0.16 percent/s for 
C-HUAEC; and 0.14 ± 0.02 percent/s for LGA-HUAEC. The half-time value was calculated 
resulting in 144.9 ± 10 seconds for C-HUAEC and 196 ± 7.6 seconds for LGA-HUAEC. 
Finally, the area under the curve (AUC) of HyPer fluorescence in LGA-HUAEC was smaller 
than C-HUAEC AUC (Table 4). All these data indicate that LGA-HUAEC present a delayed 
and diminished oxidation of the HyPer probe by H2O2, suggesting that these cells have a 
constitutional efficient intracellular antioxidant machinery.  
Hyper signal recovery results, which indicate the reduction of disulfide bond on the 
biosensor, gives an idea of reductive capacity of cells. To check if LGA-HUAEC had an 
altered reductive system, we compared the decay of biosensor signal during first 260 seconds 
after H2O2 withdrawal. Figure 1F and Table 4 show significant differences between the 
fluorescence level reached by C- and LGA-HUAEC in the recovery curves. The slope of the 
decreasing curve (80 to 180 s) was -0.23 ± 0.05 and -0.48 ± 0.04 for C-HUAEC and LGA-
HUAEC, respectively. The fluorescence decay half-time was calculated in 123.4 ± 11.9 
seconds for C-HUAEC whereas for LGA was 140 ± 4.1 seconds. On the other hand, AUC 
analysis confirms that recovery of the biosensor signal was significantly lower in LGA-
HUAEC compared to control (Table 4). These results indicate a higher and faster rate of 
recovery of the probe, and therefore a higher capacity to reduce H2O2-oxidized cysteine 
residues in LGA-HUAEC.  
The results obtained with this tool, that allows the monitoring of the peroxide neutralizing 
system and disulfide reducing activity in vivo, indicate that LGA-HUAEC seem to have a 
more robust antioxidant/reductive system compared to Control cells. 
LGA-HUAEC have reduced superoxide anion level and increased SOD activity 
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To evaluate if increased basal level of H2O2 in LGA-HUAEC could be due to an increase in 
SOD activity, the levels of superoxide anion, using the DHE fluorescent probe and the SOD 
activity were measured in C- and LGA-HUAEC. Figure 2A shows that LGA-HUAEC 
present a significant reduction of DHE and an increased SOD activity (Figure 2B). 
LGA-HUAEC have reduced GSH:GSSG ratio 
Since increased levels of H2O2 in LGA-HUAEC suggest an intracellular pro-oxidant 
environment, the levels of reduced (GHS) and oxidized (GSSG) glutathione were measured, 
and the GHS:GSSG ratio calculated. As shown in Figure 2C, the GSH:GSSG ratio is reduced 
in LGA-HUAEC, associated to a diminished level of GSH (Figure 2D), without changes in 
the GSSG levels (Figure 2D), when compared to C-HUAEC. 
LGA-HUAEC do not present changes in pro- or antioxidant proteins expression 
We later quantified pro- and antioxidant protein levels in C- and LGA-HUAEC to verify if 
the results obtained with the HyPer probe could be explained with changes in the expression 
of some of the proteins involved in the intracellular oxidative status. Figures 3A and 3B 
show representative Western blots of NRF2, NOX4, HMOX1 and GPX1, SOD1, 
respectively, using β-actin as an internal control. Although, NOX4 (Figure 3C) and GPX1 
(Figure 3G) protein levels are elevated in LGA-HUAEC, the difference with C-HUAEC did 
not reach statistical significance, as well as HMOX1 (Figure 3D), NRF2 (Figure 3E), and 
SOD1 (Figure 3F). These data suggest that the protein levels in the HUAEC homogenates 
do not explain the functional results revealed by HyPer.  
Umbilical arteries endothelium from LGA newborn form women with pregestational 
obesity (LGA-OM) show altered levels of pro- and anti-oxidant enzymes 
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To evaluate the in situ levels of pro- and antioxidant enzymes, histological sections from 
umbilical cords from Control and LGA-OM were immunoassayed for NOX4, GPX1 and 
SOD1 enzymes (Figure 4A). As shown in Figure 4B, the reciprocal intensity of NOX4 and 
SOD1 are increased in LGA-HUAEC; however, the GPX1 did not show any difference 
between the groups. 
LGA-HUAEC have altered NRF2 and HMOX1 gene expression 
To verify whether LGA-HUAEC´s augmented reducing capacity could be due to an altered 
antioxidant machinery, including transcriptional activation of genes, we determined the 
expression of several genes involved in the intracellular redox homeostasis. Using qPCR we 
calculated the relative quantity of NRF2, FOXO3A, HMOX1, GPX1, TXNDR, PRDX3, 
PRDX6, SOD1, SOD2, p66sch and NOX4 mRNAs in both C- and LGA-HUAEC (Figures 
5A-5K). However, the transcripts that could explain the biosensor data such as GPX1, 
TXNDR, PRDX3, PRDX6, SOD1, SOD2, p66sch and NOX4 mRNAs showed no significant 
differences between groups. Conversely, a decrease in NRF2 (Figure 5A) and an increase in 
HMOX1 gene expression (Figure 5C), which is a target of Nrf2, was observed in LGA-
HUAEC.  
LGA-HUAEC overexpress the GPX1 gene when exposed to a pro-oxidant stimulus 
Following one of the premises of the “Developmental origins of health and disease 
(DOHaD)”, where it has been proposed that the intrauterine oxidative stress milieu can 
reprogram the development and function of the offspring´s cardiovascular system, we 
decided to evaluate the response of LGA-derived HUAEC to an oxidative challenge. To test 
this, HUAEC where exposed to a moderate oxidative challenge (100 M H2O2, 3 hours) after 
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which gene expression was evaluated. We detected a tenfold increase in GPX1 mRNA levels 
in LGA-HUAEC, with no difference in C-HUAEC. Other transcripts such as NRF2, PRDX3 
and SOD1 showed no differences between groups (Figure 6A). This result suggests that 
LGA-HUAEC could have some early programming of oxidative stress response during 
intrauterine life. 
GPX1 gene transcription start site has an open state of chromatin in LGA-HUAEC 
To evaluate if epigenetic mechanisms could be implicated in the increased gene expression 
of GPX1 in H2O2-challenged LGA-HUAEC compared to C-HUAEC, we assessed the 
chromatin state of GPX1, NRF2, HMOX1, PRDX3 and SOD1 transcription start site (TSS). 
The magnitude of DNA digestion by DNase I depends directly on the chromatin state of the 
region evaluated. If chromatin has an open state (reduced nucleosome occupancy) DNase I 
can digest more DNA than in a closed state of the chromatin. In our approach, gDNA relative 
quantity after digestion was normalized by a constitutive closed chromatin region at PAX7 
TSS. Results show that there is no difference in the state of the chromatin at NRF2, HMOX1, 
PRDX3 and SOD1 TSS between LGA- and C-HUAEC. However, there was a higher DNA 
digestion in the GPX1 TSS of LGA-HUAEC, indicating a more open state of chromatin in 
this proximal promoter site, compared to C-HUAEC (Figure 6B). 
 
DISCUSSION 
Among chronic diseases, cardiovascular conditions have become one of the most common 
causes of death worldwide. It is now very clear that intrauterine environment has a pivotal 
role in the risk of developing cardiovascular disease later in life. Large for Gestational Age 
58 
 
(LGA) newborn have an increased hazard risk of developing metabolic syndrome in their 
childhood (Boney et al., 2005). LGA newborn from women with obesity present increased 
oxidative stress markers in the umbilical cord (Malti et al., 2014; Saker et al., 2008) 
associated with a decreased relaxation of chorionic arteries (Schneider et al., 2015). 
However, the cellular and molecular mechanisms by which this intrauterine environment can 
program the artery endothelial cell response to an oxidative challenge have not been clarified. 
The results shown in this work indicate that LGA-HUAEC presented a basal pro-oxidant 
status characterized by increased H2O2 levels and decreased GSH:GSSG ratio. The cells also 
have lower levels of superoxide anion associated to a high superoxide dismutase activity and 
elevated SOD1 and NOX4 protein levels in LGA-derived umbilical artery endothelium. A 
pro-oxidant challenge (peroxide) unveiled an increased H2O2 buffering capacity and an 
elevated disulfide reducing activity in LGA-HUAEC together with altered gene expression 
of critical antioxidant enzymes and changes in chromatin structure in the promotor of GPX1, 
strongly suggesting the participation of epigenetic mechanisms (summarized in Figure 7). 
Earlier evidence have pointed out to oxidative stress as a common feature in the 
cardiovascular programming in LGA offspring (Malti et al., 2014; Schneider et al., 2015). 
However, to date no report has shown the mechanisms involved in this adaptation in artery 
endothelial cells isolated from LGA newborn exposed to maternal pregestational obesity. 
The H2O2-biosensor HyPer, which has been useful to characterize redox homeostatic changes 
in living cells (Kallens et al., 2017; Román et al., 2017), evidenced that LGA-HUAEC 
elicited an increased oxidative tone at steady-state. The later could be explained by the 
elevated SODs activity together with the higher in situ SOD1 protein expression, which is 
supported by the reduced level of superoxide anion observed in LGA-HUAEC. The increased 
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expression of  NOX4 in LGA-derived umbilical artery endothelium, could be participating 
in the altered redox status in this condition (Martyn et al., 2006). All these findings reflect 
the fine equilibrium between oxidative and reductive forces operating simultaneously in 
LGA-HUAEC. 
Glutathione (GSH) is the major non-enzymatic cellular antioxidant (Dickinson & Forman, 
2002). Glutathione peroxidases (GPX) uses GSH to reduce oxidized proteins generating the 
oxidized form of glutathione (GSSG) (Brigelius-Flohé & Maiorino, 2013). The intracellular 
GSH:GSSG ratio is broadly used to evaluate cell redox status (Locigno & Castronovo, 2001; 
Noctor & Foyer, 1998). The observation in our model that LGA-HUAEC had a lower 
GSH:GSSG ratio, due to lower levels of GSH, support the proposal that these cells exhibit a 
pro-oxidant status, as suggested by the results with the HyPer probe. 
The analysis of the kinetics of the HyPer probe signals are useful to visualize the intrinsic 
components of the antioxidant machinery could be participating in the LGA-induced redox 
adaptations. The rate of the rising signal observed in the biosensor after the exogenous H2O2 
pulses reflect the combination of two cellular aspects: the H2O2 permeability at plasma 
membrane defined mainly by aquaporins (Bienert & Chaumont, 2014; Miller et al., 2010) 
and the capacity of H2O2 to oxidize thiols on cytoplasmic proteins, since HyPer depends of 
peroxiredoxins (Stöcker et al., 2017). Our experiments indicate that after H2O2 exposure, 
LGA-HUAEC produce a slower increase in the biosensor signal compared to control cells, 
indicating that these cells better endure extracellular oxidant challenges. Moreover LGA-
HUAEC showed to be more efficient to recover the HyPer signal than control cells, likely 
due to a better adapted machinery to reduce disulfide bonds on cytoplasmic proteins. Thus, 
60 
 
we propose that a chronic pro-oxidant fetal environment could modify the antioxidant 
machinery performance in LGA-HUAEC. 
Then we decided to evaluate if there was an altered expression of antioxidant-related genes 
in LGA-HUAEC. Edlow et al. (2016) analyzed the cord blood transcriptome of the offspring 
from mothers with obesity, evidencing an altered segregation of mRNAs related to 
inflammatory signaling, glucose/lipid metabolism and ROS homeostasis, in comparison to 
newborn from lean mothers (Edlow et al., 2016). In non-human primates, the mRNA of the 
reductive enzyme Rdh12 was increased, among other candidate genes analyzed, in the liver 
of the offspring of dams fed a high-fat diet (Aagaard-Tillery et al., 2008). Under basal 
conditions, we found that LGA-HUAEC have a down regulation of NRF2 and an increase in 
HMOX1 mRNA, both antioxidant proteins, indicating a possible programming of gene 
expression associated to a chronic pro-oxidant milieu secondary to maternal obesity.  
The lack of induction of NRF2 mRNA by oxidative stress could be explained by the fact that 
NRF2 actions depend mainly on its protein degradation/stabilization, and less on its gene 
transcription. It has been reported that NRF2 is constitutively degraded at the proteasome by 
a Keap1-dependent ubiquitination (McMahon et al., 2003; Nguyen et al., 2005). Oxidative 
stress induces the release of NRF2 from Keap-1, allowing its stabilization and nuclear 
translocation, where it binds to the gene promoter of target genes (Nguyen et al., 2003). This 
action of NRF2 does not depend on its transcription rate but mainly on its protein stability 
and nuclear translocation (Nguyen et al., 2009). In the Western blot experiments performed, 
the whole cell homogenates were analyzed, and no difference in the NRF2 protein was 
observed in LGA-HUAEC, compared to C-HUAEC. This result does not allow to 
differentiate between cytosolic and nuclear NRF2 protein location, which would have been 
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an interesting contribution to these data. 
Remarkably, LGA-HUAEC showed an overexpression of GPX1 mRNA in response to H2O2 
treatment, compared to Control, resembling the Epigenetic Transcriptional Memory (ETM) 
described in immune cells exposed to inflammatory mediators (D´Urso & Brickner, 2016; 
Gialitakis et al., 2010). The ETM has been defined as an inducible gene overexpression when 
the same gene has been previously exposed to the same stimuli (Gialitakis et al., 2010; Light 
et al., 2013). ETM is explained by a first stimulus inducing regulatory proteins recruitment 
and an open state of the chromatin at the transcription start site (TSS) of inducible genes. The 
TSS of GPX1 gene in LGA-HUAEC showed a higher DNase sensitivity, indicating an open 
state of the chromatin. This could be due to a previous regulatory protein recruitment that 
induced an enhanced response to the H2O2 challenge. If we consider the previously reported 
pro-oxidant environment in LGA fetuses from women with pregestational obesity (Malti et 
al., 2014; Catalano & Shankar, 2017), it is reasonable to ponder that oxidative response genes 
in LGA-derived HUAEC have been chronically stimulated during pregnancy, causing an 
epigenetic effect that can be mitotically inherited to cellular progeny. This mechanism could 
underlie the maintenance of an elevated risk of fast-onset endothelial dysfunction by future 
stressors in these subjects during their postnatal life (Gaillard, 2015). 
The findings described here suggest the participation of oxidative stress, particularly H2O2, 
in the NO-dependent endothelial dysfunction observed in placental arteries from LGA 
newborn (Schneider et al., 2015). After 10 minutes of H2O2 stimulation, a PI-3K/Akt-
dependent endothelial Nitric Oxide Synthase (eNOS) activation is observed in bovine aortic 
endothelial cells (BAEC)(Cai et al., 2003). However, BAEC treated for 24 h with H2O2 
showed reduced levels of tetrahydrobiopterin (BH4), a limiting cofactor for eNOS activity, 
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and its reducing enzyme dihydrofolate reductase (DHFR) (Chalupsky & Cai, 2005), leading 
to eNOS uncoupling and shifting to a superoxide producing enzyme (Förstermann & Münzel 
2006). Thus, we propose that the previously described pro-oxidant intrauterine environment 
in pregnancies with LGA from women with obesity (Malti et al., 2014), leads LGA-HUAEC 
to shift to an adapted oxidative status. By the other hand, in genetic and chemical-induced 
oxidative cell models, a reduction of the GSH:GSSG ratio has been associated to endothelial 
dysfunction (Espinosa-Díez et al., 2018); characterized by eNOS uncoupling induced by 
elevated eNOS S-glutathionylation (Crabtree et al., 2013; Espinosa-Díez et al., 2018) and 
BH4 oxidation to BH2 (Crabtree et al., 2013). Our group has previously shown evidence for 
eNOS inactivation in LGA-HUAEC (Muñoz-Muñoz et al., 2018). 
In order to survive, prokaryotic and eukaryotic cells have the ability of modify their cellular 
physiology in response to a pro-oxidant environment (Crawford & Davies, 1994; Lushchak, 
2010). In the non-dividing human retinal pigmented epithelial cell line, chronic treatment 
with nonlethal H2O2 concentrations induced an increment of cell viability after lethal H2O2 
treatment (3 mM, 1 h). The later was achieved due to high levels of catalase, CuZn-SOD and 
GPX1 activity (Jarrett and Boulton, 2005). A similar hormetic effect was found in mouse 
embryonic fibroblast (MEF) cells subjected to repeated treatments with low concentrations 
of H2O2 (Pickering et al., 2013). Hence, we propose that LGA-derived HUAEC, which are 
chronically exposed to a pro-oxidant intrauterine environment, exhibit an oxidative 
adaptation characterized by an increased superoxide neutralizing system, higher SOD 
activity, SOD1 and NOX4 induced protein expression and an open chromatin status at the 
GPX1 TSS.  
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Following the line of thought that support the early origins of chronic diseases (DOHaD), we 
propose that fetal endothelial cells from the offspring of women with pregestational obesity, 
exposed to oxidative stress during fetal development, can reprogram the redox system at a 
cellular and epigenetic level, to trigger a faster and more efficient response to subsequent 
oxidative-related insults.  
CONCLUSIONS 
This work evidences for the first time an increased antioxidant machinery performance in 
HUAEC isolated from LGA newborn from women with pregestational obesity, could impact 
the offspring´s endothelial function at birth. Based in the findings in gene expression and 
chromatin structure we propose that detrimental fetal environment could epigenetically 
modify gene expression and thus function in endothelial vascular cells (Block & El-Osta, 
2017; Mcmillen, 2005).  The long-term effects of these cellular adaptations need to be further 
studied in the postnatal life of LGA offspring, to confirm that these early findings induced 
by an altered maternal and fetal nutritional environment during pregnancy could lead to 
higher cardiovascular risk (Adamo et al., 2012; Oken & Gillman, 2003). 
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TABLES 
Table 1. Baseline characteristics of the study population. 
 
Control group 
n = 20 
LGA group 
n = 21 
Gestational age (weeks) 38.5 ± 0.53 38.6 ± 0.19 
Newborn Birth weight (g) 3464± 75.44 4168 ± 39.31**** 
Height (cm) 50.8 ± 0.60 52.2 ± 0.23** 
Ponderal index 2.7 ± 0.07 2.9 ± 0.04** 
Gender F/M  8/12  8/13 
Maternal weight (g) 70.5 ± 1.20 88.2 ± 2.39**** 
Maternal height (m) 1.6 ± 0.01 1.6 ± 0.02 
Maternal BMI 27.7 ± 0.18 34.0 ± 0.91**** 
Ponderal index expressed as birth weight x 100 x height-3 (g x cm-3), and maternal body 
mass index (BMI) expressed as kg x m-2. F and M indicate total number of female or male 
neonates. Values are mean ± S.E.M. or frequency. ***p < 0.001 ****p < 0.0001 
determined by Mann-Whitney test or Chi2, accordingly. 
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Table 2. Primers sequences and amplification conditions for mRNA RT-qPCR 
mRNA  
Target 
Forward Sequence 
5¨--- 3¨ 
Reverse Sequence 
5¨--- 3¨ 
Annealing 
T° 
Efficiency  
(%) 
NRF2 caactactcccaggttgccc agtgactgaaacgtagccga 58° 109,5 
HMOX1 caaagtgcaagattctgcccc caactgtcgccaccagaaag 58° 96 
FOXO3A acaaacggctcactctgtcc ggatggagttcttccagccg 60° 105 
GPX1 agtgcgaggtgaacggtgcg ggggtcggtcataagcgcgg 58° 94 
PRDX3 tgccattccttggggcatt catgaggaactggtgctgaat 58° 102,9 
PRDX6 ctcgggactttaccccagtg tgatatccttgctccaggca 58° 92,2 
TXNDR1 gcatttgcagcagagcgaaa tgccctcctgataagcaagaa 58° 97 
SOD1 ggtgtggccgatgtgtctat cctttgcccaagtcatctgc 58° 90,6 
SOD2 tggggttggcttggtttcaa tagtaagcgtgctcccacac 58° 97,9 
NOX4 tccagtccttccgttggtttgc cctttgcccaagtcatctgc 58° 99,4 
p66sch gaacaaatcacacctctgggc cattgaagaattcaggggtcca 60° 99,5 
ATP5F1 gccctgacagattctcctatcg caatacccctggacctaggaag 58° 103 
RPLP0 aatctccaggggcaccattg gaacacctgctggatgacca 58° 93 
RPLP2 gcgccaaggacatcaagaag ccagcaggtacactggcaa 56° 96 
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Table 3. Primers sequences and amplification conditions for gDNA qPCR 
gDNA 
Target 
Forward Sequence 
5¨--- 3¨ 
Reverse Sequence 
5¨--- 3¨ 
Annealing 
T° 
Efficiency  
(%) 
NRF2 TSS ctggagttcggacgctttga ttctcgggcggtaaagtgag 58 98 
HMOX1 TSS tggccagactttgtttccca tgaggacgctcgagaggag 58 97 
GPX1 TSS ggacgcgtgctcctcctaag cccacatcctaactcaggaacc 64 103 
PAX7 TSS taaaagaaaagtccgaacctatc gtttcagggctggacgga 60 90 
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Table 4. Parameters of HyPer fluorescence kinetics in C-HUAEC and LGA-HUAEC. 
 
  
C-HUAEC LGA-HUAEC 
Increment Maximum reached (%)    115.7 ± 53.5     41.29 ± 23.4**** 
 
Slope (percent/s)    0.83 ± 0.16       0.14 ± 0.02**** 
 
Half-time (s) 144.9 ± 10       196 ± 7.6**** 
 
AUC       18089 ± 11749       4480 ± 2683*** 
Recovery Minimum reached (%)   58.94 ± 38.2     11.42 ± 27.1**** 
 
Slope (percent/s)    -0.23 ± 0.05      -0.48 ± 0.04**** 
 
Half-time (s)    123.4 ± 11.9      140 ± 4.1**** 
 
AUC    18644 ± 3619     13441 ± 3969**** 
 
Maximum and minimum reached are the last data collected in increment and recovery curves, 
respectively. The slope of each curve was calculated between 80 and 180 seconds, which 
matches a clear increase and reduction of fluorescence in the increment and recovery curves, 
respectively. AUC= Area under the curve. Values are mean ± SEM. *** p < 0,001, ****p < 
0,0001 determined by t-test with Welch´s correction (C-HUAEC n= 3, 21 experimental 
replicates and LGA-HUAEC n=3, 57 experimental replicates). 
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FIGURE LEGENDS 
 
Figure 1. Indirect H2O2 measurement in C-HUAEC and LGA-HUAEC by HyPer under 
basal and oxidative stress conditions. (A) and (B) Representative data obtained by HyPer 
in Control- and LGA-HUAEC, respectively. After transduction of HUAEC with HyPer, cells 
were washed and placed with Krebs buffer to achieve resting conditions. Under an 
epifluorescence microscope, excitation was performed at 420 and 490 nm and fluorescence 
was acquired at 530 nm every 20 sec for resting conditions and after a curve of H2O2 
concentration (1 to 200 µM) for each experiment, ending with a 1000 µM dose for calibration 
purposes. (C) Basal fluorescence of HyPer-probe in C- and LGA-HUAEC. Fluorescence at 
the end stabilizing stage were compared between C-HUAEC and LGA-HUAEC. In the box 
plots, the mean, the interquartile range are indicated. The end of whiskers indicate the 
minimal and maximal values, respectively. **** p<0.0001, Mann-Whitney test. (D) The 
H2O2 concentration-response curve. The highest fluorescence reached with every H2O2 
concentration were used to calculate and to compare EC50, in C- and LGA-HUAEC, in a 
normalized percentage of response vs log H2O2 concentration curve. EC50 were 44.89 and 
104.9 μM for C-HUAEC and LGA-HUAEC, respectively. Values are mean ± S.E.M. (C-
HUAEC n= 3, 21 replicates and LGA-HUAEC n=3, 57 replicates). (E) HyPer signal 
increment following H2O2 challenge. A normalized percentage of response vs time (seconds) 
was made with fluorescence collected during the first 300 seconds of 100 µM H2O2 
treatment. C-HUAEC data fitted in a Non-Linear Boltzman sigmoidal curve. Lineal 
regression was used to calculate LGA-HUAEC fluorescence kinetic data. Values are Mean 
± S.E.M. **** p< 0.0001, Two-way ANOVA, Bonferroni's multiple comparisons test. (C-
80 
 
HUAEC n= 3, 14 replicates and LGA-HUAEC n=3, 49 replicates) (F) HyPer signal reduction 
following H2O2 withdraw. A normalized percentage of response vs time (seconds) was made 
with fluorescence collected during the first 260 seconds after H2O2 withdraw. Linear 
regression was used to calculate both C- and LGA-HUAEC fluorescence kinetic data. Values 
are Mean ± S.E.M. *** p< 0.001, Two-way ANOVA, Bonferroni's multiple comparisons test 
(C-HUAEC n=3, 21 replicates and LGA-HUAEC n=3, 57 replicates). 
 
Figure 2. Basal superoxide anion level, SODs activity and quantitative measurement of 
GSH and GSSG in C-HUAEC and LGA-HUAEC. (A) Superoxide anion determination. 
C- and LGA-HUAEC were incubated with DHE 10 mM for 30 min at 37°C in darkness, 
washed 3 times with PBS previous incubation with DAPI 300 nM for 5 min in darkness at 
room temperature. Excesses of fluorescent molecules were rinsed 3 times. Cells were 
maintained Krebs buffer in darkness and immediately measured in a multiplate reader. DHE 
and DAPI fluorescence were acquired at (excitation/emission) 490/580 nm and 358/461 nm, 
respectively. ** p<0.01, Mann-Whitney test, (C-HUAEC n= 5, LGA-HUAEC n=5). (B) For 
SODs activity, C- and LGA-HUAEC lysate (50 µL) were used to determine the reduction of 
cytochrome c by the superoxide radical in the xanthine/xanthine oxidase system. The activity 
was measured by 2 min at 37°C in spectrophotometer at 550 nm. * p<0.05, Mann-Whitney 
test (C-HUAEC n= 5, LGA-HUAEC n=5). (C, D and E) For the GSH/GSH assay, the C- and 
LGA-HUAEC lysate (100 µL) were incubated to 37°C and mixed with of KPE buffer, 
NADPH and DTNB to oxidize all GSH to GSSG and produce the TNB chromophore. The 
rate of TNB formation was followed by 2 min at 412 nm. The rate was compared with a 
standard curve of GSH and GSSG in buffer. ** p<0.01, **** p<0.0001, Mann-Whitney test. 
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(C-HUAEC n= 5, LGA-HUAEC n=5). In the box plots, the mean, the interquartile range are 
indicated. The end of whiskers below and above the box indicate the minimal and maximal 
values, respectively. **** p<0.0001, Mann-Whitney test.  
 
Figure 3. Basal Protein level of antioxidant and pro-oxidant enzymes in C-HUAEC and 
LGA-HUAEC. (A) and (B) are representative Western blots for the proteins analyzed. The 
relative amount of NRF2 (C), HMOX1 (D), GPX1 (E), SOD1 (F) and NOX4 (G) between 
C- and LGA-HUAEC is presented. In the box plots, the mean, the interquartile range are 
indicated. The end of whiskers below and above the box indicate the minimal and maximal 
values, respectively. **** p<0.0001, Mann-Whitney test (C-HUAEC n= 8, LGA-HUAEC 
n=11).  
Figure 4. Umbilical artery endothelium in situ levels of H2O2 producing and reducing 
enzymes in Control and LGA-MO umbilical cords. (A) Representative microphotography 
from histological sections of umbilical cords stained for NOX4, SOD1 and GPX1. The 
intensity of DAB, in endothelial cells, was measured using HDAB color deconvolution plug-
in of Fiji version of ImageJ software. Scale bar = 200 μm. (B) Statistical analyses of 
reciprocal intensity from NOX4, SOD1 and GPX1 in Control and LGA-MO umbilical cords. 
In the box plots, the mean, the interquartile range are indicated. The end of whiskers below 
and above the box indicate the minimal and maximal values, respectively. ** p<0.01, **** 
p<0.0001, Mann-Whitney test (C-HUAEC n=5 and LGA-HUAEC n=5), where 40 groups of 
6 cells (C-HUAEC) and 57 groups of 6 cells (LGA-HUAEC) were analyzed. 
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Figure 5. Basal mRNA level of genes involved in the antioxidant and pro-oxidant 
response in C-HUAEC and LGA-HUAEC. Total RNA was extracted with Trizol® and 
quantified. The cDNA was obtained from 500 ng of RNA by reverse transcription. Relative 
quantities of mRNA for NRF2 (A), FOXO3A (B), HMOX1 (C), GPX1 (D), TXNDR (E), 
PRDX3 (F), PRDX6 (G), SOD1 (H), SOD2 (I), p66sch (J) and NOX4 (K) comparing between 
C-HUAEC and LGA-HUAEC was performed by qPCR.  In the box plots, the mean, the 
interquartile range are indicated. The end of whiskers below and above the box indicate the 
minimal and maximal values, respectively. * p< 0.05 **p< 0.01, Mann-Whitney test (C-
HUAEC n= 4, LGA-HUAEC n=7). 
 
Figure 6. Transcript levels of antioxidant and pro-oxidant genes after H2O2 treatment 
and its chromatin accessibility in C-HUAEC and LGA-HUAEC. (A) Transcript levels of 
NRF2, HMOX1, GPX1, PRDX3 and SOD1 genes in C-HUAEC and LGA-HUAEC after 
H2O2 treatment. Cells were challenged with 100 μM of H2O2 for 3 h. Then, total RNA was 
extracted with Trizol® and quantified, 500 ng of RNA were reverse transcribed, and qPCR 
was performed. Values are mean ± S.E.M. * p< 0.05 vs C-HUAEC, Mann-Whitney test (C-
HUAEC n= 3, LGA-HUAEC n=3). (B) DNase hypersensitivity assay for antioxidant gene 
promoters. Primary C-HUAEC and LGA-HUAEC were lysed and the DNA obtained was 
digested with zero or 6,25 U of DNase I for 5 minutes at 22°C.  The Genomic DNA (gDNA) 
was extracted by phenol-chloroform method and quantified. Using 25 ng of gDNA, relative 
quantities of NRF2, HMOX1 and GPX1 gDNA were calculated using PAX7 as endogenous 
control. Values are mean ± S.E.M. * p< 0.05 vs C-HUAEC, Mann-Whitney test (C-HUAEC 
n= 3, LGA-HUAEC n=3). 
83 
 
 
Figure 7. HUAEC from LGA-MO newborn show a pro-oxidant status and a higher 
antioxidant performance. The altered redox status of LGA-HUAEC is characterized by 
increased H2O2 level and decreased GSH:GSSG ratio. The cells also showed a diminished 
level of superoxide anion associated to a high activity superoxide dismutases; associated to 
elevated protein levels of SOD1 and NOX4, both H2O2 producer enzymes. A pro-oxidant 
challenge revealed in LGA-HUAEC an increased H2O2 buffering capacity and an elevated 
reductive activity. In front of an oxidative stimulus, in LGA-HUAEC GPX1 gene was 
overexpressed associated with an open chromatin structure at basal level, strongly suggesting 
the participation of epigenetic mechanisms. 
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FIGURES 
 
Figure 1. Indirect H2O2 measurement in C-HUAEC and LGA-HUAEC by HyPer under basal and 
oxidative stress conditions 
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Figure 2. Basal superoxide anion level, SODs activity and quantitative measurement of GSH and 
GSSG in C-HUAEC and LGA-HUAEC.  
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Figure 3. Basal Protein level of antioxidant and pro-oxidant enzymes in C-HUAEC and LGA-HUAEC.  
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Figure 4. Umbilical artery endothelium in situ levels of H2O2 producing and reducing enzymes in 
Control and LGA-MO umbilical cords. 
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Figure 5. Basal mRNA level of genes involved in the antioxidant and pro-oxidant response in C-
HUAEC and LGA-HUAEC.  
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Figure 6. Transcript levels of antioxidant and pro-oxidant genes after H2O2 treatment and its 
chromatin accessibility in C-HUAEC and LGA-HUAEC.  
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Figure 7. HUAEC from LGA-MO newborn show a pro-oxidant status and a higher antioxidant 
performance.  
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CHAPTER III 
 
NRF2 PRE-RECRUITMENT AT ENHANCER2 IS A HALLMARK OF H2O2-
INDUCED EPIGENETIC TRANSCRIPTIONAL MEMORY IN HMOX1 IN HUMAN 
ENDOTHELIAL CELLS. 
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ABSTRACT 
Maternal obesity is a major cause of increased cardiometabolic risk in the offspring. Large 
for gestational age newborns from obese mothers, present endothelial dysfunction in 
chorionic and umbilical arteries. Alterations in physiologic and cellular redox status are 
strongly associated with altered gene regulation in arteries from large for gestational age 
newborn. However, specific mechanisms by which the pro-oxidant fetal environment could 
modulate gene expression during the offspring lifespan are still elusive. Here, we evidence 
that oxidative-stress can reprogram the stimulus-response of antioxidant coding-genes, by 
epigenetic transcriptional memory mechanism.  Using an H2O2 double-hit-protocol we found 
that HMOX1 gene presents an ETM-like response, associated with chromatin structure 
changes at the HMOX1 gene regulatory regions. The ETM-like response was characterized 
by a paused-RNAPII and NRF2 enrichment at transcription start site and enhncer2 of 
HMOX1 gene, respectively. Here we show that ETM can be induced by an oxidative 
challenge, suggesting that ETM could be one of the epigenetic mechanisms involved in fetal 
programming. 
 
Keywords: Epigenetic transcriptional memory, oxidative stress, HMOX1, NRF2, 
endothelium. 
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INTRODUCTION 
Obesity is a global epidemic(1). Maternal obesity has been related to increased 
cardiometabolic risk in the offspring during lifespan(2,3). Endothelial dysfunction has been 
found in chorionic arteries isolated from large for gestational age (LGA) newborn from obese 
mothers (OM), associated with an anomalous response to oxidative stress(4).  Previous 
reports evidence an increase in oxidative stress markers in the umbilical cord and peripheral 
blood from LGA newborn and OM, respectively(5). Suggesting that oxidative stress possibly 
plays a pivotal role in the detrimental fetal programming of vascular function. 
In the vasculature, the main source of ROS are NADPH oxidases (NOX), Xanthine 
oxidoreductase (XOR), uncoupled endothelial nitric oxide synthase (eNOS) and 
mitochondrial respiration complexes(6,7). By the other hand, there are several antioxidant 
systems such as the thioredoxin, peroxiredoxin or glutathione systems that protect or repair 
the damage caused by reactive oxygen species (ROS) or reactive nitrogen species 
(RNS)(8,9). The implication of oxidative stress in anomalous vascular function is clear since 
exogenous antioxidants as N-acetylcysteine (NAC)(4) and sulforaphane(10) decrease 
endothelial dysfunction.  
Notably, the relationship between a pro-oxidant milieu and metabolic diseases has been 
clearly established. Male mice that overexpress Glutathione peroxidase 1 (GPX1) developed 
higher body weight and insulin resistance(11). The phenomenon of hyperglycemia-induced 
metabolic memory in antioxidant-coding genes is due to epigenetic mechanisms (12). The 
later, as well as other reports, have evidenced that detrimental metabolic states can induce 
permanent changes in antioxidant cellular systems(13–15).  
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In previous unpublished results, our group found that in human umbilical artery endothelial 
cell (HUAEC) isolated from LGA newborn NRF2 and HMOX1 mRNA basal level was 
downregulated and overexpressed, respectively. Interestingly, after H2O2 treatment GPX1 
gene expression was tenfold higher in LGA-HUAEC than Control-HUAEC, suggesting to 
epigenetic transcriptional memory (ETM) as a possible underlying mechanism. 
ETM is the mechanism, in which genic response to a first induction is “remembered”, 
inducing an over-expression of the same gene by a second stimulus (Reviewed in (16)). The 
memory can be maintained by four or five cell divisions, without any re-stimulation in the 
meantime(17–19). The events and mechanisms that control ETM have been studied mainly 
in eukaryotic cells, in both yeast and human cells. The features that characterize ETM can be 
summarized as follows: 1) The second gene induction is faster and stronger compared to the 
first induction(20); 2) the “memory” is maintained up to five cell divisions(18); 3)the locus 
of genes that acquire ETM are recruited to nuclear boundary during gene transcription and 
they stay there for 4 to 12 hours after gene expression(20); 4) the proximal-promoter of 
primed genes have an open state of chromatin(17); 5) it could there be a long-range 
interaction between gene regulatory regions (e.g., proximal promoter and enhancers), 
forming a chromatin loop, sustained by cohesins(21); 6) also, incorporation of histone 
variants H2A.Z to proximal-promoter chromatin region(20),(22); and, 7) an enrichment of 
H3K4me2 histone modification and poised-RNAPII during “resting period” (after the first 
activation)(19,23). In general, in vitro ETM experimental design includes a double-hit-
protocol, where two stimuli are separated by several cellular divisions(17,19). 
Here, we propose here that oxidative-stress can induce, by itself, an ETM-like response in 
antioxidant coding-genes. To evaluate our hypothesis we tested oxidant stressors in a double-
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hit-protocol on Control-HUAEC and endothelial cell line EA.hy926. The models allowed to 
evaluate chromatin-related features associated with ETM, increasing the knowledge about 
the gene regulation by oxidative stress. 
RESULTS 
H2O2-priming induces an epigenetic transcriptional memory-like response in primary 
HUAEC  
To evaluate the hypothesis proposed, a double-hit-protocol using classical oxidative stressors 
was applied. As a first attempt, a double-hit-protocol with 40 μM tBHQ in quiescence-
induced HUAEC was implemented, mimicking post-mitotic state of endothelial cells in vivo 
(Supplementary Figure 1A). Several mRNA levels of candidate genes were determined by 
qPCR. There were no differences between cells treated once or twice (Supplementary 
Figure 1B). Since it has been described that mRNA transcription and translation are stopped 
during mitosis(24), we decided to introduce a cellular proliferative step between the first and 
second stress, including cell splitting. Using the experimental design described in Figure 1A 
it was possible to get four different experimental conditions i) cells that were 
Unprimed/Untreated (UP/UT), ii) Primed/Untreated (P/UT), iii) Unprimed/Treated (UP/T) 
and iv) Primed/Treated (P/T). Using 100 µM H2O2 as a stressor in priming and treatment, we 
found that HMOX1 mRNA accumulation was increased in P/T cells in comparison to UP/T 
cells (Figure 1C). The mRNA levels of as NRF2 (Figure 1B) or GCLM (Figure 1D) did not 
show any difference. Using tBHQ as the stressor, neither NRF2, HMOX1 nor GCLM 
expressed differential mRNA levels between UP/T and P/T cells, (Figures 1E, 1F, and 1G, 
respectively). 
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These data show that an ETM-like response can be induced by H2O2 in primary HUAEC. 
H2O2-priming induces an epigenetic transcriptional memory-like response in EA.hy926 
cells.  
. Using the experimental design described in Figure 2A, only HMOX1 mRNA showed an 
ETM-like response in P/T cells when H2O2 was used as a stressor. On the other hand, tBHP 
or tBHQ showed no difference in mRNA expression between UP/T and P/T cells (Figure 
2C and 2D, respectively). NRF2, GPX1, GCLM or NQO1 mRNA levels, also were analyzed, 
showing no difference in gene expression (Supplementary Figure 2). 
To evaluate whether the H2O2-induced ETM-like response in the HMOX1 gene is specific to 
endothelial cells or it could be a general cellular response, we try double-hit-protocol in HeLa 
cells. As in EA.hy926 cells, HMOX1 gene showed an ETM-like response, but in this case, 
using tBHP as a stressor (Supplementary Figure 3C). 
Interestingly, H2O2-priming induced a diminishing of proliferation rate in EA.hy926 and 
HeLa cells (Supplemental figure 5A and 5C, respectively). However, H2O2 priming in 
EA.hy926 cells did not change cellular sensitivity to a high concentration of H2O2 
(Supplemental figure 5B). 
Summarizing, HMOX1 showed a consistent ability to respond to oxidative stress in an ETM-
like manner in both human endothelial and carcinogenic cell lines. 
mRNA accumulation in P/T cells is not caused by an alteration in mRNA decay 
The increment of HMOX1 mRNA level in P/T cells could be an effect of an alteration in 
mRNA decay. To evaluate this option, HMOX1 mRNA half-life was calculated in the four 
experimental conditions generated by H2O2 double-hit-protocol in EA-hy926. After inducing 
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an ETM-like response, using 100 μM of H2O2 for 3h (Figure 3A), general transcription was 
stopped by treatment with Actinomycin-D (10 µM for 0, 2, 4, 6 or 8 h) and the mRNA levels 
were measured by qPCR. HMOX1 mRNA level at each time-point was calculated relative to 
untreated cells. Using the curves shown in Figure 3B, HMOX1 mRNA half-life was 
calculated: UP/UT= 4.7 h, P/UT= 5.7 h, UP/T= 2.8 h and P/T= 2.9 h. 
The results indicate that treated cells have a shorter mRNA half-life than untreated. However, 
there is no difference between mRNA half-life UP/T and P/T, indicating that ETM-like 
response is not related to an altered mRNA decay. 
H2O2-primed cells have an open state of chromatin in the HMOX1 regulatory regions 
Previously, ETM has been related to chromatin structure modification at the core promoter 
of the HLA-DRA gene(17). Thus, we decided to evaluate DNase I accessibility to regulatory 
regions of the HMOX1 gene, including the transcription start site (TSS), Enhancer 1 at about 
-4kb (E1) and Enhancer 2 at -9 kb from TSS (E2). To evaluate the priming effect on 
chromatin accessibility, we only included the UP/UT and P/UT conditions at the end of the 
double-hit-protocol, in EA.hy926. Following the DNase I HS protocol(25), chromatin was 
partially digested by 0, 6.25, 12.5 and 25 U of DNase I. After DNA extraction, regions of 
interest were amplified by qPCR. The PAX7 TSS region was used as an endogenous control 
to calculate the relative quantity of gDNA. Using this experimental approach, we found that 
in P/UT cells, E2 and TSS region of HMOX1 were more digested than UP/UT cells (Figures 
4B and 4D, respectively), evidencing that H2O2 priming in those regions induces an open 
state of the chromatin, suggesting the participation of epigenetic mechanisms in this 
condition. 
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Phospho-S5-RNAPII at TSS and NRF2 at E2 are enriched in H2O2-primed cells  
In previous models of ETM, the open state of the chromatin observed in primed cells has 
been related with an enrichment of RNAPII protein complex(17,19). To determine if H2O2-
induced ETM had similar features the enrichment of RNAPII-CTD, RNAPII phosphorylated 
at serine 5 (pS5-RNAP) of CTD and NRF2 at regulatory regions of the HMOX1 gene were 
evaluated, using ChIP-qPCR. the The data obtained showed that the TSS region of HMOX1 
had a significant enrichment of RNAPII and pS5-RNAP in P/UT cells, compared to UP/UT 
cells (Figures 5A and 5C, respectively). Also in P/UT cells, E2 showed a significant 
enrichment of NRF2 (Figure 5E). These results indicate that chromatin structure 
modifications, induced by the H2O2-priming, were related to an enrichment of crucial 
transcription-related proteins in the core promoter of HMOX1. 
pS5-RNAPII and NRF2 enrichment is not different between UP/T and P/T cells 
To evaluate if priming was related to an enrichment of RNAP-CTD, pS5-RNA and NRF2, at 
HMOX1 gene regulatory regions, in UP/T and P/T cells, was calculated. As is showed in 
Figures 5B, 5D and 5F, there was no difference in the enrichment levels of these proteins, 
indicating that after 3 h of H2O2 treatment, at least in the evaluated proteins, the 
transcriptional behavior is the same in both experimental conditions. 
DISCUSSION  
Intrauterine life impacts cardiometabolic performance during lifespan (Reviewed in(26)); a 
phenomenon identified as fetal programming(27). Epigenetic has been the most logic 
mechanism that can explain the phenomenon (Reviewed in (28–30)). However, specific 
mechanisms are still elusive. Previously, our group demonstrated that fetal chorionic arteries 
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from LGA newborn from OM have endothelial-dysfunction associated to an altered 
antioxidant defence (4). Unpublished data indicated that, in LGA-HUAEC, GPX1 gene has 
an increased response to an H2O2 challenge. We then proposed that the pro-oxidant fetal 
environment, observed in maternal obesity(31), could act as a chronic stress to endothelial 
cells, inducing ETM in antioxidant coding-genes. To evaluate if oxidative stress by itself can 
induce ETM in antioxidant-coding genes, a previously reported double-hit-protocol(17,19) 
was used. In order to mimic the in vivo cellular state, we tried the double-hit-protocol in 
quiescent cells, induced by serum starvation. Using that approach there were no differences 
between cells treated once or twice. These results were interpreted as in quiescent cells, the 
first stress increased antioxidant proteins levels; then, buffering the second challenge and 
normalizing the gene activation.  Then, we introduced a proliferative step in the double-hit-
protocol. The results, from that approach, indicated that the HMOX1 gene showed an ETM-
like response in Control-HUAEC, EA.hy926 and HeLa cells, and this was not related to an 
alteration of mRNA stability. Changes in chromatin structure in HMOX1 gene regulatory 
regions were associated to an enrichment of total RNAPII, RNAPII phosphorylated at serine 
5 (pS5-RNAPII), a mark of the paused RNAPII, and NRF2 enrichment at the TSS and 
Enhancer 2, respectively.  
Here, we show that H2O2 can induce ETM in endothelial cells, characterized by an NRF2 
pre-recruitment in Enhancer 2, suggesting ETM as a possible mechanism involved in the 
programming of endothelial dysfunction. 
It is known that oxidative stress induces an adaptive response in prokaryotic and eukaryotic 
cells(32). However, in several publications using double-hit protocols, both challenges were 
done in the same cell cycle(33,34). The latter suggests an adaptive response due to the 
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overexpression of antioxidant enzymes/scaffolds induced by the first challenge, which allows 
the cell to survive to a second oxidative challenge. A similar effect could ensue in the first 
experimental design, in which two challenges were made in serum-starved culture media, 
which induces cell quiescence(35). 
In order to evaluate the effect of oxidative-stress on gene expression, a turning-off of the 
transcriptional machinery was attempted. Gottesfeld(24), indicated that during cellular 
division general gene expression is silenced. Then, in the experimental protocol, a 
proliferative step between two challenges was introduced, reinforced by cellular 
trypsinization and reseeding. Using the new approach it was obtained an ETM-like response 
at HMOX1 gene; which not only occurred in HUAEC and EA.hy926 cells, by H2O2 treatment 
but also in HeLa cells, using tBHP as a stressor. These results indicated that oxidative stress 
is able to induce an ETM-like response, by itself; which it is not a cell-type dependent effect.  
In stimuli-responsive genes, ETM is associated to epigenetic modifications made by a first 
stimulus, also called gene priming; which favors an over-expression of the gene when cells 
are stimulated again (mechanisms are reviewed by D´Urso and Brickner(36)). ETM has been 
induced in chicken Hsp70 gene by heat(37), in IL2 gene among others in Jurkat cells by 
phorbol 12-myristate 13-acetate (PMA) combined with calcium ionophore (PMA/I)(38); and 
in HLA-DRA gene among others using INF-γ in HeLa cells(17,19). However, the ETM-like 
response by oxidative stress in primary human cells or human cell lines has not been reported.   
Previous unpublished data suggested that GPX1 gene in LGA-HUAEC could have acquired 
ETM due to the pro-oxidant environment developed in obese pregnant. Contrary to the 
expected, the gene did not show any over-induction after second stimuli with stressors, 
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suggesting that oxidative-stress, per se, it is not sufficient to alter gene expression of GPX1. 
Further experiment must be made to find the possible mechanism. 
Several publications indicated that HMOX1 mRNA half-life increased when gene expression 
is induced by hypoxia(39), shear-stress/atorvastatin(40) or nitric oxide(41). We evaluated if 
H2O2 induced ETM-like response is related with an altered HMOX1 mRNA decay, pointing 
to possible post-transcriptional mechanisms. Contrary to published data, in our model mRNA 
half-life were longer in non-treated cells than treated cells. We think that, in EA.hy926 cells, 
the high amount of HMOX1 mRNA could be detrimental for the cell. Then, it is necessary to 
reduce elevated mRNA level quickly. However, there was no difference in the HMOX1 half-
life between unprimed or primed conditions, indicating that mRNA decay mechanisms are 
not altered in ETM-like response. 
An open state of chromatin at gene promoters also is associated with ETM(17). If the region 
of interest in the genome has a small nucleosome occupancy (open state chromatin), 
endonucleases (in this case DNase I) are able to digest gDNA easier than a region with high 
nucleosome occupancy (closed state of chromatin). Using a modified protocol of DNase HS 
assay, we found that, in primed cells, the regulatory regions Enhancer2 and TSS, of the 
HMOX1 gene, have an increased accessibility to the endonuclease. Suggesting that, in our 
model, epigenetic mechanisms could be involved. Since RNAPII enrichment at gene 
promoter of primed genes has been also described in ETM(21), we decided to evaluate 
RNAPII enrichment at HMOX1 gene regulatory regions. H2O2-primed EAhy926 showed a 
significant enrichment of RNAPII at HMOX1 TSS. Contrary to data reported by Light et 
al.(19), we found also an enrichment of pS5-RNAPII modification, evidencing an paused-
RNAPII recruitment (Reviewed in (43,44)). Compared to untreated state, when both 
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unprimed and primed cells were stimulated, the enrichment of RNAPII and its serine-5 
phosphorylation level decreased. A possible explanation is that during productive elongation 
phase, RNAPII goes into gene-body(44), decreasing its presence at gene promoter. 
After oxidative or electrophilic stress, NRF2-sMAFG/K heterodimer binds at Enhancer1 (-
4kb) and Enhancer2 (-9kb) of HMOX1 gene(45) inducing its transactivation(46). In the H2O2-
primed cell, we found a clear enrichment of NRF2 in Enhancer 2. As a similar phenomenon, 
Tu et al. described ETM of TNFSF10 gene, induced by PMA/I, associated with chromatin 
structure changes and the enrichment of transcription factor ETS-1 at the gene enhancer(38). 
Although it has been reported that NRF2 can be retained at nucleus by heterodimerization 
with sMAFG(47), the mechanism of inheritance through cell cycle are not reported yet. 
Possibly an alteration in NRF2 nuclear exportation after gene transactivation(48) maintains 
to NRF2 bound. An interesting finding was reported in NF-E2p45, another member of 
the family of transcription factors(49) which NRF2 belongs(50). Xin et al. evidenced an 
enrichment of NF-E2p45 at β-globin enhancer/promoter gene during mitosis, acting as a 
bookmark of previously activated genes(51).  
Further studies must be done to fully depict the epigenetic mechanisms that underlie H2O2-
induced ETM. Since BACH1 has been evidenced as a MAFK-dependent HMOX1 
repressor(52,53), to evaluate its enrichment at HMOX1 enhancers in H2O2-primed cells 
becomes relevant. However, other ETM general mechanism could be found in our model. 
Specific histones modifications, as H3K4me2 at core-promoter(17,19) of HLA-DRA gen or 
H3ace and H4ace at core-promoter/enhancers of FOS gene(21), has been associated 
respectively to INF-γ-induced and PMA/I-induced ETM. Changes in DNA methylation have 
previously been described. After the first stimulus, demethylation at specific CpG of IL2 
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enhancer induced Oct-1 transcription factor recruitment conducting to an increased response 
to a second stimulus (54). Interestingly, the HMOX1 gene has a CpG island at TSS region 
(from -97 to +163) with 37 CpG; Enhancer 2 also has a high amount of CpGs 
(Supplementary Figure 2). Contrarily to the TSS region, that does not possess an ARE 
motif, Enhancer 2 has CG dinucleotide in three of its five non-canonical ARE motifs, 
enabling that changes in the methylation of these CpGs could underlie NRF2 enrichment in 
H2O2-primed cells. 
Summarizing, we have evidenced that oxidative stress can induce ETM as a general cellular 
mechanism. We propose that this phenomenon could be one of the epigenetic mechanisms 
that programs endothelial dysfunction in offspring of women with pregestational obesity. 
Further studies are necessary to depict hormonal or stress associated cellular signaling, 
epigenetic remodelling of chromatin and their possible impact on the cardiovascular 
physiology.  
MATERIAL AND METHODS 
Samples  
This research was conducted in accordance with the Declaration of Helsinki and Ethics 
Committee approval from the Faculty of Medicine at the Pontificia Universidad Católica de 
Chile and by the FONDECYT, as well as patient informed consent were obtained. Placentae 
were collected immediately after delivery from full-term pregnancies from normotensive, 
non-smoking, non-alcohol or drug consuming mothers, without intrauterine infection or any 
other medical or obstetrical complication. Maternal nutritional status was calculated by 
maternal BMI at delivery corrected by the gestational age (55). Using the National standard 
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curve(56) newborn where classified according to birth weight and gestational age at birth in 
adequate (AGE) or large for gestational age (LGA) if their percentile was between 10th and 
90th  (control group) or > 90th percentile respectively. 
 
Cell isolation and culture  
Human umbilical artery (HUAEC) were isolated as described(57). Briefly, endothelial cells 
were isolated from umbilical arteries by collagenase digestion (0.2 mg/mL) and cultured (37 
°C, 5% CO2) up to passage 4 in medium 199 (M199) containing 5 mmol/L D-glucose, 10% 
newborn calf serum, 10% fetal calf serum, 3.2 mmol/L L-glutamine and 100 U/ mL 
penicillin-streptomycin. The medium was fully replaced every 2 days until confluence. Prior 
to extraction confluent cells were exposed to normoxia using a gas mixture (5% CO2-
balanced N2) to obtain 5% O2 [oxygen partial pressure (PO2) ~33.9 mmHg, normoxia for 
these endothelial cells] in a hypoxia chamber connected to a PROOX 110 device 
(BioSpherix, NY, USA), deprived of growth factor (overnight) and then exposed to double-
hit-protocol. 
EA.hy926 cells were kindly donated by Dr. Simone Mörtl (AG Klinische Strahlenbiologie, 
Helmholtz Zentrum, München). EAhy926 and HeLa Cells were grown in Iscove's Modified 
Dulbecco's Medium (Thermo Fisher Scientific) supplemented with sodium bicarbonate 
(3.024 g/L) and 10% Fetal bovine serum (GIBCO), under standard conditions (37 °C, 5% 
CO2). Cells were split every 2 days and cultured in fresh media. 
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Treatments 
The double-hit-protocols were performed with H2O2 (100 µM), (Merck, USA); tert-Butyl 
Hydroquinone, (tBHQ, 10, 20 or 30 µM) (Sigma,Germany); or tert-Butyl Hydroperoxide, 
(tBHP, 20 or 40 µM) (Sigma, Germany). Actinomycin-D (10 µM) (GIBCO, USA) was used 
for the mRNA decay assay. DNase HS assay was made using DNase I, RQ1, endonuclease 
(Promega, USA). 
Isolation of total RNA and reverse transcription  
Total RNA was isolated using Trizol (Invitrogen, USA) as described(58). RNA quality and 
integrity was ensured by gel visualization and spectrophotometric analysis (OD260/280) and 
quantified at 260 nm. Aliquots of 500 ng of total RNA was reversed transcribed using 
IMPROM II RT kit (Promega, USA).  
Relative Quantitative of mRNA 
Polymerase chain reactions were performed as described(57), using oligonucleotide primers 
for human genes of interest (GOI) GCLM, GPX1, HMOX1, NRF2 or NQO1. Three different 
mRNAs, RPLP0, RPLP2 and ATP5F1, were used as reference genes for quantification (for 
primers specification see supplemental table 1). Quantification was carried out using the 
algorithm proposed by Pfaffl(59). GOI mRNA level was relative to the three different 
reference genes.  
mRNA decay assay 
Assay was conducted as described(60). At the end of double-hit-protocol, cells were treated 
with 10 µM of Actinomycin-D for 0, 2, 4, 6 and 8 hrs. At each time point, RNA was extracted 
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with Trizol and retrotranscribed. HMOX1 mRNA relative level was determined by qPCR. 
Using PAX7 TSS region as endogenous control. 
DNAse Hypersensitivity assay 
The original protocol by Stewart et al.(25) was used, with some modifications. Briefly C-
HUAEC and LGA-HUAEC were cultured in 6 well plates until confluence. After washing 
with PBS (2X), in vivo partial DNA digestion was reached by adding 1 mL of digestion buffer 
(15 mM Tris-HCl pH 7.5, 60 mM KC1, 15 mM NaCl, 5 mM MgCl2, 0.5 mM EGTA, 300 
mM sucrose, 0.5 mM 2-mercaptoethanol, 0.5% NP40 and freshly added 0 U (Control) or 
6.25 U of RQ1 DNase (Promega)). After incubation for 5 min at room temperature (22-25°C), 
the digestion buffer was aspirated and cells were lysed with 0.5 mL of lysis buffer (50 mM 
Tris-HCl pH 8.0, 20 mM EDTA, 1% SDS, 200 µg/mL Proteinase K  (Thermo Scientific) and 
20 µg/mL RNase A(Affymetrix, USA) and incubated for 1 h at 37°C. DNA was extracted by 
the phenol-chloroform method(61). Twenty five ng of DNA per reaction were used for 
amplifying NRF2 transcription start site (TSS), HMOX1 TSS and GPX1 TSS (GOI). The 
PAX7 TSS was used as the reference gene (Primer details in Supplementary Table 1). 
Quantification of DNA was carried out using the algorithm proposed by Pfaffl (59). 
Chromatin immune precipitation (ChIP) assay  
The ChIP assays was performed as previously described(62). Briefly, chromatin was 
crosslinked with 1% of formaldehyde in PBS and incubated for 15 min at room temperature. 
Cells were lysed and sonicated to shear chromatin. Immunoprecipitation was made with the 
following antibodies: RNAPII-CDT (1 ug; clone 8WG16, #ab817, Abcam), RNAPII-CDT 
phosphorylated at serine 5 (1 ug; #ab513, Abcam) and NRF2 (5 ug, D1Z9C, Cell signaling). 
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Crosslinking was reverted and bound DNA was extracted using the phenol:chloroform 
method(61). Quantitaive PCR was made with 2 uL of sample per reaction for HMOX1 TSS, 
Enhancer 1 and Enhancer 2 regions (Primer sequences are described in Supplementary 
Table 1). The amount of immunoprecipitated DNA in each sample was calculated using % 
of input analysis. 
Statistical analysis. 
The experiments were done in 3 different control-HUAEC and LGA-HUAEC. In EA.hy926 
and HeLa cells the replicates were three or more, as indicated in the figure legend. Values 
shown are mean ± S.E.M. Comparisons between different experimental conditions were 
analyzed using Two-way ANOVA, Bonferroni's multiple test, considering p< 0.05 as the 
statistical significance threshold. All the analyses were carried out with the statistical 
software GraphPad Prism 6.01 (GraphPad Software Inc., San Diego, CA, USA). 
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FIGURES 
 
 
 
Figure 1. NRF2, HMOX1 and GCLM mRNA level induced by double-hit-protocol in Control-
HUAEC. (A) The double-hit-protocol scheme in primary Control-HUAEC. Before priming and 
treatment, cellular quiescence was induced by reduction of MVGF to 2% and atmospheric O2 to 8%, at 
least for 18 h. Priming and treatment were made with  H2O2 (100 µM) or tBHQ (40 µM) for 3 h. After 
priming, cells were left proliferate in normal culture conditions (21 h, 20% MVGF) and later trypsinized, 
split and seeded in new plates. Another 21 h of incubation in normal conditions occurred before 
quiescence induction and treatment (as described previously). The mRNA levels of (B) NRF2, (C) 
HMOX1 and (D) GCLM, induced by the H2O2 double-hit-protocol. The mRNA levels of (E) NRF2, (F) 
HMOX1 and and (G) GCLM induced by the tBHQ double-hit-protocol. Values are mean ± S.E.M. * p< 
0.05, Unprimed vs Primed conditions. Two-way ANOVA, Bonferroni's multiple comparisons test. n=3. 
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Figure 2. HMOX1 mRNA level induced by the double-hit-protocol in EA.hy926. (A) H2O2 Double-
hit-protocol scheme for EA.hy926 cells. Priming and treatment were made using H2O2, tBHP or tBHQ. 
After priming, cells were left to proliferate (21 h) before trypsinization, splitting and re-seeding in new 
plates. (B) HMOX1 mRNA level in a time-curve of H2O2 treatment, in Unprimed and Primed cells with 
H2O2 (100 µM, 3 h). One cycle of proliferation-split-proliferation during 48 h occurred before the second 
treatment with the same stressor and concentration, for 0.5, 1, 2, 3, 6 and 24 h. (C) Priming with tBHP 
(10 μM) and a second treatment with 0, 10, 20 or 30 µM of tBHP (3 h) (D) Priming with tBHQ (20 μM) 
and second treatment with 0, 20 or 40 µM of tBHQ (3h). Values are mean ± S.E.M. **** p< 0.0001, 
Unprimed vs Primed condition.  Two-way ANOVA, Bonferroni's multiple comparisons test. n=3. 
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Figure 3. HMOX1 mRNA half-life after double-hit-protocol in EA.hy926 cells. (A) Using H2O2 as a 
stressor (100 μM), the double-hit-protocol was applied to EA.hy926, and HMOX1 mRNA level was 
quantified. (B) At the end of the protocol, the four experimental conditions were treated with 
Actinomycin-D (10 µM for 0, 2, 4, 6 and 8 h). For each experimental condition, HMOX1 mRNA level 
was calculated (relative to 0 h of treatment). The data obtained were fitted to an exponential function 
and mRNA half-life calculated. Values for the different conditions were UP/UT= 4.7 h; P/UT= 5.7 h; 
UP/T= 2.8 h; P/T= 2.9 h. Values are mean ± S.E.M. n=3. 
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Figure 4. DNase I chromatin accessibility at HMOX1 gene regulatory regions in Unprimed and 
Primed EA.hy926. (A) HMOX1 gene regulatory regions scheme, indicating sites of RNAPII and NRF2 
enrichment described in the literature. EA.hy926 cells were primed or not with 100 µM H2O2 for 3 h. Then, 
the protocol described in Figure 2A was followed, but without any second treatment. in vivo gDNA 
digestion was made with 0, 6.25, 12.5 and 25 units of DNase I for 5 minutes at room temperature before 
cellular lysis and DNA extraction. gDNA relative quantity was calculated for HMOX1 Enhancer 2 (B), 
Enhancer 1(C) and TSS (D). PAX7 TSS was used as an endogenous control gene. Values are mean ± S.E.M. 
* p< 0.05, Unprimed Vs Primed condition.  Two-way ANOVA, Bonferroni's multiple comparisons test. 
n=3. 
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Figure 5. Enrichment of total RNAPII, pS5-RNAPII and NRF2 at HMOX1 regulatory regions of unprimed 
or primed EA.hy926 cells in basal or induced transcriptional state. To analyze the basal transcriptional state, 
EA.hy926 cells were treated with H2O2 (100 µM, 3 h). Then, the protocol described in Figure 2A was followed, 
without the second treatment. Finally, ChIP assays were performed (see Methods) for (A) RNAPII, (C) pS5-
RNAPII and (E) NRF2 and the HMOX1 TSS, Enhancer 1 and Enhancer 2 were amplified. Values are mean ± 
S.E.M. *p< 0.05 **p< 0.01 for Unprimed vs Primed condition.  Mann-Whitney test. n=6. For induced 
transcriptional level, double hit protocol was followed, including the second treatment with H2O2 (100 µM, 3 h). 
(B) RNAPII-total, (D) pS5-RNAPII and (F) NRF2 were immunoprecipitated and HMOX1 TSS, Enhancer 1 and 
Enhancer 2 were amplified. Values are mean ± S.E.M. n=3.  
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Supplementary Table 1. Primers specifications. 
Target gene Ref. number ID Sense Antisense 
 Annealing 
°C 
Efficiency 
% 
mRNA  
NRF2 NM_001145412.2 AGGTTGCCCACATTCCCAAA ACGTAGCCGAAGAAACCTCA 58° 109 
HMOX1 NM_002133.2 AAGACTGCGTTCCTGCTCAA GGGGGCAGAATCTTGCACTT 58° 96 
GPX1 NM_000581.2  AGTGCGAGGTGAACGGTGCG GGGGTCGGTCATAAGCGCGG 58° 94 
GCLM NM_002061.3  GCACAGGTAAAACCAAATAG GGATCATTGTGAGTCAAC 60 91 
NQO1 NM_000903.2  CCAGATATTGTGGCTGAA CTCTCCTATGAACACTCG 60 107 
RPLP0 NM_001002.3 AATCTCCAGGGGCACCATTG GAACACCTGCTGGATGACCA 58° 93 
RPLP2 NM_001004.3 AGCGCCAAGGACATCAAGAA TAACCTTGTTGAGCCGGTCG 56° 96 
ATP5F1 NM_001688.4 GCCCTGACAGATTCTCCTATCG CAATACCCCTGGACCTAGGAAG 58° 103 
gDNA  
PAX7 TSS NC_000001.11  TAAAAGAAAAGTCCGAACCTATC GTTCAGGGCTGGACGGA 60° 90 
HMOX1 
TSS NC_000022.11 TGGCCAGACTTTGTTTCCCA TGAGGACGCTCGAGAGGAG 58° 97 
HMOX1 E1  NC_000022.11 AGTCGCGATTTCCTCATCCC GAGAAGCTGAGGAGGCACTG 60° 93 
HMOX1 E2  NC_000022.11 CTGCTGAGTAATCCTTTCCCGA GGGGATTAAACCTGGAGCAGC 60° 109 
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Supplementary Table 2. Predicted NRF2-binding sites. HMOX1 gene regulatory 
regions were inspected for NRF2 binding sites (ARE motif) using TBIND online-tool 
(http://tfbind.hgc.jp/; Bioinformatics, Vol.15, No.7/8, pp.622-630, 1999.) 
Regulatory Region Strand Canonical motif Predicted motif 
Similarity 
(1 =100%) 
Enhancer 2 (+) TGCTGASTCAY TGCTGAGTAAT 0.91 
 
(+) TGCTGASTCAY TGCTGAGTCAC 1.00 
 
(+) TGCTGASTCAY CGCTAAGTCAC 0.89 
 
(+) TGCTGASTCAY CGCTGAGTCAC 0.98 
 
(+) TGCTGASTCAY CGCTGAGTCAC 0.98 
Enhancer 1 (+) TGCTGASTCAY TGGCGAGTCAC 0.81 
 
(+) TGCTGASTCAY TGCTGAGTCGC 0.91 
 
(+) TGCTGASTCAY TGCTGCGTCAT 0.90 
 
(+) TGCTGASTCAY TGCTGAGTCAC 1.00 
 
(+) TGCTGASTCAY TGCTGGGTCCC 0.86 
Core  promoter (-) TGCTGASTCAY GGGCATCAGCT 0.81 
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Supplementary Figure 1. Effect of tBHQ double-hit-protocol in antioxidant proteins mRNA level 
in Control-HUAEC. (A) The double-hit-protocol scheme in quiescent primary Control-HUAEC. 
Before priming cellular quiescence was induced by reduction of MVGF to 2% and atmospheric O2 to 
8%, at least for 18 h. The cells were primed or not with 40 µM tBHQ for 3 h. After priming, the fresh-
deprivation medium was renewed and cells were incubated for another 21 h. To both unprimed and 
primed cells a treatment of 40 µM tBHQ for 3 h was applied. (B) Levels of NRF2, HMOX1, GPX1, 
GCLC and GCLM mRNAs induced by double-hit-protocol.  
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Supplementary Figure 2. NRF2, GPX1 and GCLM mRNA level induced by double-hit-protocol in 
EA.hy926. Double-hit-protocol was applied to EA.hy296 cells using H2O2, tBHQ or tBHP as stressors. 
(A) In the same experiment shown in Fig.2 B NRF2 mRNA level was calculated. (B) 3 h of H2O2 
treatment was selected to evaluate GPX1 mRNA level in unprimed and H2O2-Primed cells. In the same 
experiment shown in Fig. 2C also was analyzed of NQO1 (C) and GCLM (D) mRNA level. In the same 
experiment shown in Fig. 2D also was analyzed of NQO1 (E) and GCLM (F) mRNA level. Values are 
mean ± S.E.M. n=3. 
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Supplementary Figure 3. HMOX1 and GCLM mRNA level induced by double-hit-protocol in HeLa 
cell. Double-hit-protocol was applied to HeLa cells using H2O2, tBHQ or tBHP as stressors. (A) HMOX1 
and (B) GCLM mRNA level were calculated using 100 µM H2O2 as stressor. (C) HMOX1 and (D) 
GCLM mRNA level were calculated using 40 µM tBHQ as stressor.  (E) HMOX1 and (F) GCLM mRNA 
level were calculated using 20 µM tBHP as stressor. Values are mean ± S.E.M. * p< 0.05, Unprimed Vs 
Primed condition.  Two-way ANOVA, Bonferroni's multiple comparisons test. n=3. 
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Supplementary Figure 4. NRF2 and NQO1 mRNA level induced by double-hit-protocol in HeLa 
cell. Double-hit-protocol was applied to HeLa cells using H2O2, tBHQ or tBHP as stressors. (A) NRF2 
and (B) NQO1 mRNA level were calculated using 100 µM H2O2 as a stressor. (C) NRF2 and (D) NQO1 
mRNA level were calculated using 20 µM tBHP as a stressor.  (E) NRF2 and (F) NQO1 mRNA level 
were calculated using 40 µM tBHQ as a stressor. Values are mean ± S.E.M. * p< 0.05, Unprimed Vs 
Primed condition.  Two-way ANOVA, Bonferroni's multiple comparisons test. n=3. 
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Supplementary Figure 5. H2O2 priming effect on cellular proliferation and on H2O2 high 
concentration resistance. (A) EA.hy926 cells (3x105) were seeded and incubated under proliferating 
condition for 24 h. The cells were then treated with H2O2 (100 µM, 3 h) and left proliferate for 21 h. 
Cells were trypsinized and counted by Trypan blue exclusion method. Values are mean ± S.E.M. *** 
p< 0.001, Unprimed vs Primed condition. Mann-Whitney test. n=6. (B) The H2O2 double-hit-protocol 
in EA.hy926 cells, where the second stress was made with 0, 100, 250, 500 µM H2O2 (6 h). Values are 
mean ± S.E.M. n= 3. (C) HeLa cells (1x105) were seeded and incubated under proliferating condition 
for 24 h. Then, cells were treated with H2O2 (100 µM, 3 h) and left proliferate for 21 h. Values are mean 
± S.E.M. n= 3. 
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Supplementary Figure 6. CpGs and NRF2 binding sites at HMOX1 regulatory regions. At A) 
Enhancer 2, B) Enhancer 1 and C) Core promoter (or TSS) are indicated RNAPII, NRF2 enrichment 
(Yellow bars) and DNase HS (grey bar) positions,  as UCSC Genome Browser on Human Feb. 2009 
(GRCh37/hg19) Assembly refers (Genome Res. 2002 Jun;12(6):996-1006). Orange bars show positions 
and sizes of PCR fragments amplified in our DNAse HS and ChIP assays. Red triangles indicate 
methylable CG dinucleotides. Green squares show the position of predicted ARE (NRF2 binding motif) 
described in Supplementary Table 2. Schemes were made with Geneious software (Biomatters Ltd.) 
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CHAPTER 4  
 
GENERAL DISCUSSION.  
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 GENERAL DISCUSSION 
CHRONIC AND ACUTE OXIDATIVE STRESS INDUCE DIFFERENTIAL 
ADAPTATIONS  IN ENDOTHELIAL CELLS  
The results shown in Chapter 2 were obtained in primary cultures of endothelium from 
umbilical arteries of the offspring of women with pregestational obesity. As described 
previously, this is a model of chronic in vivo oxidative status. By the other hand Chapter 3 
describes the mechanisms involved in the in vitro oxidative challenge in a human endothelial 
cell line. Although both Chapters try to unveil the molecular mechanisms involved in the 
chronic and acute adaptations to oxidative stress in human endothelium, for the purpose of 
highlighting the results observed in both models, the results will be discussed separately.  
Chapter 2: Human umbilical artery endothelial cells from Large-for-Gestational-Age 
newborn from women with pregestational obesity have increased antioxidant 
efficiency and gene expression. 
In this in vivo model of chronic exposure to oxidative stress, at a basal level we found that: 
1) HUAEC from LGA newborn presented higher O2
¯
 levels, SOD activity, and H2O2 tone, 
compared to the control group; 2) reduced GSH:GSSG ratio ; 3) increased HMOX1 mRNA 
and reduced NRF2 mRNA levels; 4) Increased in situ protein level of NOX4 and SOD1 and 
5) an open state of chromatin in GPX1 gene promoter. In a stimulated state LGA-HUAEC 
showed: 1) an enhanced GPX1 expression, 2) a more efficient antioxidant machinery. 
Altogether the data indicate that LGA-HUAEC have an altered cellular and molecular 
antioxidant system. 
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A clear pro-oxidant environment was found in LGA-HUAEC evidenced by a high H2O2 tone 
and reduced GHS/GSSG ratio, suggesting the participation of oxidative stress in the NO-
dependent endothelial dysfunction observed in placental arteries from LGA newborn1. Other 
reports showed that bovine aortic endothelial cells (BAEC) treated for 24 h with H2O2 
showed reduced levels of tetrahydrobiopterin (BH4), a limiting cofactor for eNOS activity, 
and its reducing enzyme dihydrofolate reductase (DHFR) 2, leading to eNOS uncoupling and 
shifting to a superoxide-producing enzyme3. Thus, we propose that the previously described 
pro-oxidant intrauterine environment in pregnancies with LGA from women with obesity 4, 
leads LGA-HUAEC to shift to an adapted oxidative status. Endothelial dysfunction also was 
found in genetic and chemically-induced oxidative stress, associated with a reduction of the 
GSH:GSSG ratio5; characterized by an uncoupled eNOS induced by its S-glutathionylation5,6 
and BH4 oxidation to BH2 
6
. Previous data in LGA-HUAEC indicated a reduction of eNOS 
activity7. 
In endothelial cells, two classical signaling pathways have been proved to be regulated by 
H2O2. One of them is VEGF and VEGF receptor 2 expression induced by H2O2, that induces 
cell growth, proliferation, and tube formation8. Also, physiological vascular relaxation is 
regulated by H2O2. Endothelial NOS activation can occur by stimulation via PI3K / Akt, ERK 
or p38 MAP kinases, which are activated by H2O2
9,10. PKG1α kinase, considered one of the 
major cGMP-independent vascular relaxation regulators11, can be activated by an H2O2-
dependent disulfur-bond formation12. However, it is important to consider that H2O2-
signaling has been described in a physiological state. Additionally, the H2O2 concentration 
threshold that unbalances the cell redox status has not been decoded.   
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Endothelial NOS (eNOS) transfers electrons from NADPH to O2, which together with L-
arginine, are key in nitric oxide (NO•) production13. In absence of its cofactors, L-arginine 
and tetrahydrobiopterin (BH4), eNOS shifts to its uncoupled state generating O2
•− instead of 
NO•14. One of the mayor endothelial alterations in LGA newborn is the presence of 
endothelial dysfunction, which is defined as the reduced capacity of a vascular bed to relax 
in an eNOS-dependent manner1. The later can be explained by an uncoupled state of eNOS, 
induced by the oxidation of BH4 to BH2 by peroxynitrite (ONOO-), a high reactive nitric 
species (RNS) formed by NO• and O2
•− during oxidative stress15; even though, it has been 
evidenced that BH2 competes with BH4 for eNOS interaction, reinforcing the uncoupled 
state of eNOS16. 
The main ROS produced by cells is O2
•−. There are three different SOD enzymes, encoded 
by different genes, that are highly compartmentalized17. SOD1, a homodimer that has copper 
and zinc in their catalytic center (CuZn-SOD), resides in the cytosol, nucleus, and 
lysosome18–20. SOD2, a homotetramer, is localized exclusively in the mitochondria, using 
manganese as a cofactor (Mn-SOD)21; and SOD3, a homotetramer that also possesses Cu and 
Zn, but is exported out of the cell (extracellular, EC-SOD)22. Our results evidenced an 
increased SODs activity and also elevated in situ protein level in LGA-HUAEC, compared 
to the control group. The latter could explain the elevated H2O2 tone indicated by Hyper since 
O2
•− is dismutated to H2O2 by members of the superoxide dismutase (SOD) family
23. In 
concordance with a systemic oxidative status described in women with pregestational obesity 
and the LGA-HUAEC response to an increment of superoxide anion production, the protein 
content of SOD and SOD activity is elevated in LGA umbilical cord blood4.  
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NADPH oxidase 4 (NOX4) is the most abundant isoform of NOX in endothelial cells24. 
NOXs uses NAPDH as an electron donor, which is transferred across cellular membranes to 
molecular oxygen, generating O2
•− 25. Although, in this thesis, the mRNA and protein level 
of NOX4 were similar between Control and LGA-HUAEC, in a primary cell culture 
approach; the in situ protein levels were increased in LGA-HUAEC. Although there is no 
direct evidence of the relation between NOX4 and endothelial dysfunction in an obesogenic 
environment, other models demonstrate that ROS produced by NOX4 uncouples eNOS; thus, 
generating endothelial dysfunction. 
In our model, the results obtained using the HyPer probe indicate that under basal conditions 
LGA-HUAEC have elevated level of H2O2. However, although there is a basal pro-oxidant 
status, this seems to be a mild-stress to which the cells can adapt. We propose that LGA 
endothelial cells adapt to overcome the intrauterine pro-oxidant status, increasing the 
efficiency of the whole antioxidant machinery, at least for H2O2. The latter is evidenced in 
the Hyper experiments, in which LGA cells were able not only to diminish the protein 
oxidation induced by an H2O2 bolus but also to reduce the oxidized proteins in a shorter 
period of time, once the stress was removed.  
 
Antioxidant gene programming by the altered maternal metabolic and pro-oxidant 
environment 
The model used, in chapter 2, were primary cell cultures of HUAEC from the offspring of 
women with pregestational obesity until passage number four. Therefore all the findings of 
this chapter, alterations of basal levels of NRF2 and HMOX1 mRNAs and increased GPX1 
gene expression in response to a new oxidative challenge, necessarily had to be inherited and 
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passed through several cell divisions. For this reason, we proposed the participation of 
epigenetic mechanisms in the “oxidative-stress memory”. This proposal was further 
confirmed when the open chromatin state in the GPX1 gene was evidenced in LGA-HUAEC.  
If we consider the “double-hit hypothesis” of DOHAD when we analyze the overexpression 
of GPX1 gene in challenged LGA-HUAEC, Epigenetic Transcriptional Memory (ETM) was 
considered as a potential mechanism which needed to be experimentally confirmed. The 
altered physiology of the maternal obesity-induced prooxidant milieu in LGA newborn 
served as first chronic stress for HUAEC.  
A link between oxidative stress and epigenetic changes had been previously proposed. El-
Osta et al. showed that ROS generated by hyperglycemia-induced the H3K4 
monomethylation by Set7/9 methyltransferase at p65 gene26. Likewise, transient high glucose 
and elevated levels of O2
-, were associated with CpG hypomethylation of the p66Shc gene 
promoter, favoring the overexpression of the pro-oxidant enzyme gene27. The hyperglycemic 
milieu induced an increase in acetylation of the histones at HMOX1 gene promoter28. This 
result evidences a mechanism that induces a permanent shift in gene expression. However, it 
was not the case of the GPX1 gene in LGA-HUAEC, in which the overexpression by 
stimulation was not associated with basal gene expression. More studies are necessary to 
depict obesity-induced hyperresponsiveness of the GPX1 gene.  
Chapter 3. Nrf2 pre-recruitment at enhancer2 is a hallmark of H2O2-induced 
epigenetic transcriptional memory in HMOX1 in human endothelial cells. 
Epigenetic transcriptional memory mechanism. 
132 
 
The epigenetic transcriptional memory (ETM) has been defined as “an adaptive system that 
permits a faster response of cells to episodic challenges such as heat stress, nutritional 
deprivation or infection”29.   
D´Urso and Brickner proposed a model of conserved and universal features of ETM, putting 
together findings from eukaryotic cells, from yeast and human29. They proposed that 
transcriptional memory requires the retention of the pre-initiation complex (PIC), mediator 
and poised RNAPII (unphosphorylated state) at the gene proximal promoter after the first 
transcription ending. The finding that CdK7 kinase is absent in this “memory complex”, was 
reported as crucial since this kinase phosphorylates C- terminal repeat domain of subunit B1 
RNAPII at serine 530, stimulating the mediator and PIC dissociation and promoting RNAPII 
escape31. These authors proposed a key role of mediator of Cdk8, facilitating the recruitment 
of a poised-RNAPII32; however, other reports indicate that Cdk8 as a critical component of 
paused-RNAPII released from HIF1A promoter under hypoxia33.  
In our model, the oxidative stress-induced ETM was associated with an open state of 
chromatin at the proximal promoter and Enhancer 2 of the HMOX1 gene of primed cells. 
This relaxed chromatin in those regions was related to both paused-RNAPII (serine 5 
phosphorylation of CTD) and NRF2 enrichment.  
The HMOX1 has a CpG island (from -97 to +163 bp, respect to TSS), which contains 35 
methylable CpG. This is very relevant since Hendrix et al. associated the stalling of RNAPII 
to genes with an elevated rate of CG dinucleotide repeats at the pausing region34. In order to 
find a difference in the methylation status of the HMOX1 CpG island that could help to 
explain the paused RNAPII enrichment in H2O2-primed cells, we sequenced that region after 
a DNA bisulfite conversion of both unprimed and H2O2-primed cells. We did not find any 
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change in methylation status between unprimed or H2O2-primed cells. Moreover, all the 
cytosines of the CpG island were unmethylated, in concordance with a previous report28.  In 
our model, changes in the methylation pattern of the CpG island of the HMOX1 gene is not 
a feature of RNAPII pausing. 
Several DNA cis-regulatory elements have been related to RNAPII pausing, such as GAGA 
element35, inverted GAGA, initiator and pause button elements34. In our model, none of them 
was found in the HMOX1 gene promoter (data not showed). 
Gene enhancers are not only involved in transcription induction but also have been involved 
in transcriptional memory mechanism. Murayama et al. showed that demethylation of a 
specific CpG of IL-2 gene enhancer favored OCT-1 transcription factor enrichment36. In a 
model of ETM of the FOS gene induced by a mitogenic stimulus, a long-range interaction 
by enhancer and the proximal promoter maintained by cohesins was found37. In our model, 
although paused-RNAPII enrichment in primed cells can explain a fast and stronger HMOX1 
expression with a second stimulus, it does not inform about the way that this enrichment 
occurs, and which is the role of NRF2 pre-recruitment at enhancer 2. 
It is known that H2O2-dependent HMOX1 gene induction is due to NRF2 activation
38. The 
HMOX1 has two regulatory regions, enhancer 2 (E2) and enhancer 1 (E1) at -9 kb and -4 kb 
from the transcription start site (TSS), respectively, in which NRF2 binds after its 
activation39,40. Using transcription binding motif predictor tool41, we found that E2 and E1 
have five ARE elements and that TSS has only one, similar to the amount proposed by 
Reichard et al.40. It can be deduced that those ARE elements could be related to ETM 
acquisition. Even more, four of the five ARE elements are non-canonical, and contains CG 
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nucleotides; perhaps the change in the methylation pattern of that specific CpGs could 
explain the NRF2 recruitment at enhancer 2. 
The possible causality of NRF2 in ETM acquisition in the HMOX1 gene is a hypothesis that 
requires confirmation. If this statement is true, ETM is a mechanism that crosses mitosis; so, 
it is possible to propose that the role of NRF2 enrichment in primed cells could be a 
bookmarking gene process. However, in stress-responsive genes, only HSP70i gene has been 
shown to be bookmarked, by the HSF2 transcription factor, during mitosis42.  
Further experiments are necessary, to completely depict the epigenetic mechanisms that are 
involved in the oxidative stress-induced ETM of HMOX1 and possibly other genes.  
Reductive stress could be part of endothelial dysfunction in LGA-HUAEC. 
The findings exposed in this thesis indicate that i) LGA-HUAEC have a more efficient 
antioxidant system, which can both reduce H2O2 protein oxidation and accelerate their 
reduction, in concomitance with, an apparent epigenetic programmed over-responding GPX1 
gene., and ii) that an oxidative stress challenge is enough to induce an ETM-dependent 
HMOX1 gene over-response, associated with NRF2 and paused-RNAPII pre-recruitment in 
upstream regulatory elements. However, from a classical point of view, an increase in the 
antioxidant capacity is associated with a healthy state; but in our model, it seems to be part 
of the vascular programming context. Then, a new question arises: What is the relationship 
between an over-responding antioxidant system and the increased cardiovascular and 
metabolic risk, observed in individuals who are born as LGA from women with 
pregestational obesity? 
We propose that both mechanisms could be part of the same metabolic-induced alterations, 
which could result in a redox status unbalance. A more efficient antioxidant system, related 
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to over-responding genes could generate reductive stress in the cells. Reductive stress is 
defined as “an abnormal increase of reducing equivalents in the presence of intact systems 
for oxidation and reduction”43, where an increment of GSH/GSSG or NAD/NADH+ ratio or 
an elevation of antioxidant enzymes expression can lead to a pathophysiological ROS decline 
(Figure 1)  
 
  
Figure 1. The redox equilibrium is essential for cellular homeostasis. Moderate reactive 
oxygen species (ROS) production leads to their effects as second messengers. However, ROS 
overproduction and/or depletion or the antioxidant enzymatic and non-enzymatic systems 
may lead to oxidative stress. Excess reducing equivalents such as reduced glutathione (GSH)/ 
oxidized glutathione (GSSG) ratio and reduced nicotinamide adenine dinucleotide (NADPH) 
can deplete all the ROS, leading to reductive stress by overexpression of an antioxidant 
enzymatic system. Moreover, chronic reductive stress may induce an oxidative stress and 
stimulated reductive stress by negative feedback regulation. Nevertheless, this process is not 
yet clearly understood. (Modified from 44) 
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Several reports show that an excessive reductive environment deregulates physiological 
functions, such as cell signaling. The over-expression of GPX1,  Prx or catalase reduce the 
cell signaling generated by growth factor receptors and cellular proliferation45,46. The 
reductive stress is characterized by an excess of GSH availability, which can lead to an 
abnormal S-glutathionylation of cysteine residues47, regulating the function of several 
proteins48.  
There is an important lack of knowledge regarding how the programmed cardiovascular 
and/or metabolic, of individuals born from mothers with obesity, system response to new 
stressors during the life span. And maybe there is not a failure of the antioxidant system but 
a stronger one. 
Conclusion and perspectives 
The original research question that guided this thesis was: Do LGA-HUAEC from women 
with pregestational obesity have an altered redox balance? In order to answer the question, 
several experimental approaches were designed. The main results that answer this question 
are summarized in Figure 2. Briefly, an elevated H2O2 basal level, high efficiency of H2O2 
buffering and an augmented reduction capacity; also, an open state of the chromatin region 
in the core promoter of GPX1 gene and overexpression of the GPX1 gene after the stimulus, 
in comparison with control cells. 
Thereafter, new questions arose such as What are the cellular mechanisms and pathways, 
altered by oxidative stress, that induce endothelial dysfunction? What are the original stimuli 
and epigenetic mechanisms involved in the permanence of the altered redox balance through 
several cell cycles? To answer the latter question we hypothesized that oxidative stress by 
itself can induce an epigenetic transcriptional memory in ARE-dependent genes. Opposing 
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to our expectations, the findings of ETM observed in primary cultured-HUAEC were not 
reproducible in an in vitro endothelial cell line exposed to chronic OxS stimuli, indicating 
that in the programming of antioxidant genes, in LGA-HUAEC from obese mother, 
additional factors participate, possibly acting in synergy with the evidenced redox imbalance. 
Epigenetic transcriptional memory (ETM) can be induced by oxidative stress (OxS) in 
the HMOX1 gene characterized by an overexpression of the gene after a second challenge 
(found in control-HUAEC, EA.hy926, and HeLa); an open state of the chromatin regions in 
Enhancer 2 and core promoter of the gene; an enrichment of NRF2 and a paused-RNAPII in 
Enhancer 2 and core  promoter, respectively (Figure 2). OxS-ETM links a physiological 
cellular phenomenon with a mechanism which seems to be part of the epigenetic repertoire 
that underlies vascular programming. However, the mechanism involved in OxS-ETM seems 
to be more complex, probably involving molecules such as BRD4, or protein complexes, as 
Mediator. Several questions await to be answered, such as Is the interaction between 
Enhancer 2 and core promoter of HMOX1 gene necessary for the acquisition of ETM? Is the 
NRF2 recruited to Enhancer 2, after the H2O2-priming, enough to transactivate gene 
transcription? Are there other genes that acquire ETM after an oxidative challenge? 
This thesis just offers a few pieces more to build the puzzle. The complete understanding 
about the mechanisms that underlie the early programming of vascular function in the 
offspring of women with pregestational obesity is far from being reached, but its 
comprehension is fundamental to offer better and opportune treatments and a better life and 
health to the future generations.  
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Figure 2. Summary of the results showed in this thesis.  LGA-HUAEC from obese 
mothers showed an increased anti-oxidant capacity characterized by an elevated H2O2 basal 
level, high efficiency of H2O2 buffering and an augmented reduction capacity, both in 
response to an exogenous H2O2 bolus. Also, SOD1 was found increased at the protein level 
and enzymatic activity. In these cells, an open state of the chromatin region containing the 
core promoter of the GPX1 gene was found, compared to control cells. After an H2O2 
challenge, GPX1 mRNA level was expressed at a higher level than stimulated control cells. 
On the other hand, using a double-hit-protocol in E.hy926 cells, H2O2 was able to induce 
epigenetic transcriptional memory in the HMOX1 gene characterized by an overexpression 
after the second challenge. The priming with H2O2 induced relaxation of the chromatin 
structure at Enhancer 2 and the core promoter of HMOX1, which is maintained after cell 
divisions. Enrichment of the transcription factor NRF2 was observed in the enhancer 2 of 
HMOX1 gene in primed cells. Also, the priming induced a pre-recruitment of paused-
RNAPII in the core promoter of the HMOX1 gene.  
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